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ABSTRACT 
 
 
 
 
Changes of histone methylation code, cytosine hydroxylation and 
formation of chromatin loops are associated with transcription 
induction by nuclear hormones, but it is not known if these events 
are the consequence or the cause of transcription initiation. 
We have studied the events induced by estrogens to stimulate 
transcription of target genes.  We find periodic oscillations of histone 
H3 methylation, G oxidation, C methylation and hydroxyl-methylation 
at the enhancer and PolyA addition sites after induction of 
transcription in prototypic estrogen-induced genes. The oscillations 
correlate with formation of chromatin loops that juxtapose the 5’ and 
3’ ends of the induced genes. BER followed by NER enzymes are 
recruited to the 5’ and 3’ end sites to repair the DNA oxidative lesions 
and to stabilize the 5’ and 3’ borders of the transcriptional units 
included in the loops. At the 5’ and  3’  end sites of the loops, 
repair of oxidized Gs and hydroxymethylated Cs proceeds in a strand 
specific fashion. 
We suggest that coupling transcription with methylation and repair 
enzymes is the evolutionary strategy to reduce the mutational burden 
induced by DNA oxidation at the borders of chromatin loops. 
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1. BACKGROUND 
 
 
 
 
1.1.     The basics: Transcription 
Transcription is the process by which the information in DNA is copied 
into messenger RNA (mRNA) for protein synthesis. It must be finely 
adjusted in order to regulate coordinately the expression of genes. 
We imagine the transcription as a dynamic process that includes several 
steps: 1. recognition of specific DNA regions; 2. modification of 
chromatin; 3. recruitment of co-transcriptional factors;  4.initiation  of 
transcription (Figure 1): 
 
 
•   Transcription: Initiation 
RNA polymerase and cofactors bind and unwind DNA, creating an 
initiation bubble. This is a DNA domain that allows RNA polymerase  to   
access a single strand of the DNA molecule. 
In eukaryotes RNA PolymeraseII (Pol II) does not contain a subunit 
similar to the prokaryotic σ factor, which can recognize the promoter and 
unwind the DNA double helix. These two functions are carried out by a 
family of proteins called general transcription factors. PolII is associated 
with six general transcription factors, designated as TFIIA, TFIIB, TFIID, 
TFIIE, TFIIF and TFIIH, where "TF" stands for "transcription factor" and 
"II" for the RNA PolII. TFIID consists of TBP (TATA-box binding protein) 
and TAFs (TBP associated factors). The role of TBP is to bind the core 
promoter. TAFs may assist TBP in this process. In human cells, TAFs are 
formed by 12 subunits. One of them, TAF250 (with molecular weight 
250kD), has the histone acetyl transferase activity, which can relieve the 
binding between DNA and histones in the nucleosome. 
The transcription factor, which catalyzes DNA melting is TFIIH. 
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However, before TFIIH can unwind DNA, the RNA PolII and at least five 
general transcription factors (TFIIA is not absolutely necessary) have to 
form a Pre-Initiation Complex (PIC). 
 
 
•   Transcription: Elongation  
One strand of DNA serves as the template for RNA synthesis, but 
multiple rounds of transcription may occur in a way that many copies of a 
gene may be produced. 
After PIC is assembled at the promoter, TFIIH can use its helicase 
activity to unwind DNA. This requires energy released from ATP 
hydrolysis. The DNA melting starts from about-10bp. Then, RNA PolII uses 
nucleoside triphosphates (NTPs) to synthesize a RNA transcript. During 
RNA elongation, TFIIF remains attached to the RNA polymerase, all other 
transcription factors dissociated from PIC. 
The Carboxyl-Terminal Domain  (CTD) of the largest subunit  of PolII is 
critical for  elongation.  In the initiation phase, CTD is un-phosphorylated,  
but  during elongation it is phosphorylated. This domain is characterized by 
proline, serine and threonine residues. 
 
 
•   Transcription: Termination 
Termination is the final step of transcription. Termination results in the  
release of the newly synthesized mRNA from the elongation complex 
(Lykke-Andersen S. et al. 2007). 
Eukaryotic protein genes contain a poly-A signal located downstream of 
the last exon. This signal  is  used  to  add  a  series  of  adenylate  
residues  (PolyA)   during  RNA processing. 
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Figure 1:Assembly of the pre-initiation complex (PIC). TBP first binds to the promoter and 
then recruits TFIIB to join TFIID (and TFIIA if present). Before entering PIC, RNA Pol II and 
TFIIF are bound together. RNA Pol II recruits TFIIE, which further recruits TFIIH to 
complete the PIC assembly. (Adapted from Molecular Biology Web Book, modified from: 
Roeder, R.G. 996. Trends in Biochem. Sci. 21:327-334). 
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1.2. Epigenetic modifications of DNA and chromatin 
 
Epigenetics is the study of modifications that induce changes in gene 
expression without any change in DNA sequence. 
Epigenetic changes are involved in development and differentiation and are 
heritable. However, environment can influence the epigenetic states and 
gene expression. Many epigenetic changes characterize the development of 
cancer and other diseases. 
 
The interaction between different epigenetic mechanisms controls the 
accessibility of genes by the transcriptional machinery. 
 
 
• Chromatin structure 
Eukaryotic   chromatin contains DNA and histones that are organized in the 
nucleosome, which consists of a histone octamer (two H2A/H2B dimers and an 
H3/H4 tetramer), around which the DNA (146 bp) is wrapped (Figure 2). 
 
 
 
 
 
 
 
Figure 2. Structure of a nucleosome, with the DNA wrapped around an octameric histone 
core (Adapted from Schneider R.et al. 2004 Nat Cell boil. 6:73-77) 
 
 
The bulk of chromatin exists as transcriptionally inactive heterochromatin, in 
which the nucleosomes are densely packaged to form a “closed chromatin 
structure”. Conversely, an “open chromatin form” is characteristic of 
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transcriptionally competent euchromatin, which has widely spaced 
nucleosomes and is accessible to the transcriptional machinery. The amino- 
terminal tails of the histones can be modified by methylation and acetylation, 
which are critical for the regulation of gene transcription. Together, these 
modifications result in a complex series of molecular events that modify the 
chromatin configuration and render genes either active or repressed. 
 
 
• Histone post-translational modifications: histone code 
 
The  amino-terminal  tail  o f   h i s t o n e s   may  undergo  a  number  of  
changes, including methylation and acetylation (Figure 3) (Andrew J 
Bannister1 and Tony Kouzarides, 2011).Together, these modifications 
modify the chromatin configuration and render genes either active or 
repressed. 
Histone methylation occurs on all basic residues: arginines, lysines and 
histidines (Fischle W.et al. 2008).  
Histone lysines may be unmethylated, or mono-, di- or trimethylated (- 
me1, -me2, -me3). 
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Figure 3: Histone modifications involved in chromatin re-organization. Histone N- tails are 
post-translationally modified, and certain combinations of histone modifications appear to 
generate a “histone code”. (Adapted from Allis et al, Epigenetics, 2006). 
 
 
The level of histone methylation is essential for regulation of transcriptional 
activity. Repressive marks include di- and trimethylation of lysine 9 on histone 
H3 (H3K9 me2/me3), trimethylation of lysine 27 on histone H3 (H3K27me3) 
and trimethylation of lysine 20 on histone H4 (H4K20 me3). Conversely, 
activation is associated with histone H3 di- and trimethylation of lysine 4 
(H3K4me2/me3) and trimethylation of lysines 36 and 79 (H3K36me3, 
H3K79me3). Methyl groups are provided to the histones by SAM/Ado-Met 
and the methylation reaction is catalysed by histone lysine methyltransferases. 
Methyl groups can also be removed from histone lysine residues by the 
action of histone lysine demethylases (Kirsten Grønbæk et al. 2008). 
These are the amine oxidases, LSD1 (KDM1) (Shi et al. 2004) and 
jumonji C (JmjC)-domain- containing, iron-dependent dioxygenases 
(Tsukada Y. et al. 2006) (Figure 4). These enzymes are highly conserved 
from yeast to humans and demethylate histone and non- histone substrates. 
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All these modifications may  act alone or in concert in a context-dependent    
manner to facilitate or repress chromatin- mediated processes (Berger 2007). 
Some histone modifications are   thought   to   influence nucleosome stability, 
but an exciting  emerging  view  is that histone  modification can  
influence  one  another such  that  one  modification recruits or activates 
chromatin-modifying complexes   to   generate   a different histone code. 
 
 
 
 
 
 
 
  
 
Figure 4: Histone lysine demethylase mechanisms. (A) JmjC proteins catalyze the 
hydroxylation of methyllysine residues in a 2-OG and Fe(II)-dependent manner, releasing 
succinate and CO2. In a second, non enzymatic step, formaldehyde is spontaneously released 
after the decomposition of the N-hydroxymethyl moiety. (B) LSD1 catalyzes the oxidation of 
the C-N methylamine bond in an FAD-dependent mechanism, producing an unstable 
intermediate that decomposes to release formaldehyde. As a consequence of this mechanism, 
LSD1 cannot eliminate trimethyllysine, whereas jmjC demethylases . (Adapted from 
Wikipedia). 
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• DNA methylation 
DNA methylation is the addition of a methyl group at the 5’-carbon of 
cytosine. In mammals, DNA methylation typically occurs in a CpG 
dinucleotide context (CpG islands). The enzymes that catalyze this 
modification are called DNA methyltransferases (DNMTs) (Law J. A. et al. 
2010). 
There are two categories of DNMTs: de novo and maintenance (Goll M. 
G. & Bestor T. H. 2005). DNMT1 is an enzyme that copies the methylation 
in hemi-methylated template (maintenance) during DNA replication and cell 
division. DNMT3a and DNMT3b are de novo methyl transferase enzymes 
that add methyl groups to unmethylated CpG in DNA. 
DNA methylation correlates with reduced transcription (Bird A. P. & 
Wolffe A. P. 1999) and it has been implicated in development and 
differentiation (Li E. et al. 1992), imprinting (Li E. et al. 1993), X 
chromosome inactivation (Panning B. & Jaenisch R. 1998), and cancer 
(Laird P. W. et al. 1995; Baylin S. B. & Ohm J. E. 2006). 
DNA  methylation  may  reduce  the  transcription  in  two  ways:  
preventing  the binding of transcriptional proteins to the gene (Choy MK et 
al. 2010) and attracting proteins known as methyl-CpG-binding domain 
proteins (MBDs). MBD proteins can recruit additional  proteins  to  the  
locus,  such  as  histone  deacetylases  and  other chromatin remodeling 
proteins that can modify histones. 
Aberrant methylation has been found in cancer cells (Cho Y. H. et al. 
2010) and it was shown that DNA methylation marks DNA damage and 
repair as a “scar” (Cuozzo C. et al. 2007) and that transcription can reduce 
the methylation on repaired DNA regions (Morano A. et al. 2014). 
However, a methyl group may be also removed by a process called DNA 
demethylation, which can either be passive or active. Passive DNA 
demethylation takes place on newly synthesized DNA strands via DNMT1 
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during replication rounds. Active DNA demethylation mainly occurs via the 
sequential modification of methylated cytosine by TET enzyme-mediated 
oxidation. The ten-eleven- translocation (TET) enzyme family of 5-mC 
hydroxylases includes TET1, TET2 and TET3. These proteins may promote 
DNA demethylation by binding to CpG rich regions to prevent unwanted 
DNA methyltransferase activity, and by converting 5-mC to 5-hmC, 5-hmC 
to 5-fC (5-formylcytosine), and 5-fC to 5-caC (5-carboxylcytosine) through 
hydroxylase activity (Figure 5). 
 
 
 
 
 
 
Figure 5: Schematic representation of DNA methylation / demethylation cycle. (Adapted 
from Yun huang, Anjana Rao. 2014 Trends in Genetics). 
 
 
The TET proteins have been shown to function in transcriptional activation. 
Furthermore, the detection of the 5-hmC or 5-fC in various tissues and cells 
may also be used as a marker to indicate active DNA demethylation. 5-fC 
can also be directly excised by thymine DNA glycosylase (TDG) to allow 
subsequent base excision repair (BER) processing, which  converts  modified  
cytosine  back to  cytosine (Adapted from Rahul M. Kohli & Yi Zhang 2013). 
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• DNA oxidation 
 
DNA oxidation is a consequence of cellular metabolism, which can increase 
as a result of toxic insults. The most common oxidized base is guanine oxidized 
to 8-oxo-7,8- dihydroguanine (8-oxo-dG). The 8-oxo-dG can base-pair with 
deoxyadenosine, instead of deoxycytotidine. This error can induce a 
transversion point mutation         (C→A)     during replication. 
Also, transcription can induce DNA oxidation. In fact, Lysine specific 
demethylase 1 (KDM1a o LSD1) is a flavin adenine dinucleotide      (FAD)-
containing enzyme,  which  demethylates  di- methyl lysine 4 (or lysine 9under 
certain conditions) and generates H2O2 during the demethylation process 
(Anand and Marmorstein 2007; Gronbaek et al. 2008; Lan et al. 2008). It 
has been shown that transient demethylation of histone H3 lysine 4 triggers 
Myc-induced transcription (Amente et al. 2010). Also, it has been found 
that Estrogen-Induced Gene Expression is driven by H3K9me2 demethylation 
(Perillo et al. 2008). In both cases LSD1 is responsible for the oxidative 
process that results in the formation of hydrogen peroxide (H2O2) whose main 
DNA product is 8-oxo-guanine (8-oxo-G) (Fig, 6) (Perillo et al. 2008). 
 
 
 
 
 
 
 
 
Figure 6: E2 induces 8-oxo-dG foci through LSD1-dependent mechanism. (Adapted  from 
Perillo et al, 2008. Science). 
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• Base Excision Repair (BER) 
 
Base excision repair (BER) is a group of enzymes that remove damaged 
bases that can otherwise cause mutations by mis-pairing or lead to breaks in 
DNA. In BER system, the damaged bases are recognized by DNA 
glycosylases, which remove specific damaged or inappropriate bases, 
forming apurinic sites. These sites are then cleaved by an AP endonuclease. 
The resulting single-strand break can then be processed by either short-
patch (where a single nucleotide is replaced) or long-patch BER (where 2-
10 new nucleotides are synthesized)(Figure 7) (Liu Y, et al. 2007). 
 
 
 
 
 
Figure 7: Scheme of base excision repair showing the two sub-pathways. The “short-patch” 
or single-nucleotide pathway, and the “long-patch” pathway. There are essentially four steps in 
the base excision repair pathway. (Adapted from Wikipedia). 
 
 
 
 
There are many DNA Glycosilases: 1. 8-Oxoguanine DNA Glycosilase 1 
(OGG1) removes 8-oxo-dG; 2. Uracil DNA glycosylase (UDG) excises the 
uracil that is the product of cytosine deamination, thereby preventing the 
subsequent C→T point mutation; 3. Timidine DNA Glycosylase (TDG) is able 
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to remove a variety of modified cytosine and 4: N-Methylpurine DNA Glycosylase 
(MPG) removes a variety of modified purine bases. 
In the short patch, the DNA polymerase β (Polβ) inserts the correct 
nucleotide and removes the deoxyribose phosphate through its associated AP-
lyase activity. The X-ray repair cross-complementing group 1 (XRCC1) acts as 
a scaffold protein to present a non-reactive binding site for Polβ and to bring 
the Polβ and LIG3 enzymes together at the site of repair (Lindahl T. & Wood 
R. D. 1999). 
An alternative pathway called “long-patch BER” replaces a strand of 
nucleotides with a minimum length of 2 nucleotides. It requires the presence of 
proliferation-cell-nuclear  antigen  (PCNA),  which  acts  as  a  scaffold  protein  
for  the  repair enzymes (Fortini P. et al. 1998). Other DNA polymerases, 
possibly Pol δ and Pol ε (Klungland A. & Lindahl T. 1997), generate an 
oligonucleotide flap. The existing nucleotide sequence is removed by flap 
endonuclease-1 (FEN1). The oligonucleotide is then ligated to the DNA by 
DNA ligase I (LIG1), sealing the break and completing the repair (Sung J. S. & 
Demple B. 2006). 
 
 
• Nucleotide Excision Repair (NER) 
 
 
Nucleotide Excision Repair (NER) acts to repair single strand breaks 
containing at least 2 bases and creating a structural distortion of the DNA. 
The same pathway may be used to repair damage from oxidative stress 
(Gros L. et al. 2002). 
There are 9 major proteins involved in NER in mammalian cells. 
Deficiencies in certain proteins lead to specific diseases; protein names are 
associated with the disease. XPA, XPB, XPC, XPD, XPE, XPF, and XPG all 
derive from Xeroderma Pigmentosum and CSA and CSB represent 
proteins linked to Cockayne syndrome. Additionally, the proteins 
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ERCC1, RPA, RAD23A, RAD23B, and others also participate in 
nucleotide excision repair. 
 
 
 
Figure 8: A model of the nucleotide excision repair pathway, which includes global 
genomic repair  and transcription-coupled repair. (Adapted from Fuss JO, Cooper PK (June 
2006). PLoS Biol). 
 
 
 
Eukaryotic nucleotide excision repair can be divided into two sub-
pathways: global genomic NER (GG-NER) and transcription coupled NER 
(TC-NER) (Figure 8). Two different sets of proteins are involved in 
recognizing DNA damage for each sub-pathway. After damage recognition, 
the two pathways converge to the steps of dual incision, repair, and ligation. 
Global genomic NER repairs damage in both transcribed and un-
transcribed DNA strands in active and inactive genes throughout the 
genome. This process is not dependent on transcription. This pathway 
employs several "damage sensing" proteins including the DNA-damage 
binding (DDB) and XPC-Rad23B complexes that constantly scan the 
genome  and  recognize  helix  distortions:  the  XPC-Rad23B complex is 
responsible for distortion recognition, while DDB1 and DDB2 (XPE) can 
also recognize some types of damage caused by UV light. 
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Instead, Transcription Coupled-NER initiates when RNA polymerase 
stalls at a lesion in DNA: the blocked RNA polymerase serves as a damage 
recognition signal, which replaces the need for the distortion recognition properties 
of the XPC-RAD23B and DDB complexes. CS proteins CSA and CSB bind some 
types of DNA damage instead of XPC-Rad23B 
Upon identification of a damaged site, subsequent repair proteins are then 
recruited to the damaged DNA to verify presence of DNA damage, excise 
the damaged DNA surrounding the lesion then fill in the repair patch. 
NER repairs the transcribed strands of transcriptionally active genes 
faster than it repairs non-transcribed strands and transcriptionally silent 
DNA. 
 
 
• Estrogen induced transcription 
The estrogen receptor (ER) belongs to a family of nuclear hormone 
receptors that act as ligand-activated transcription factors (Heldring N. et al. 
2007). The binding of ligand induces a conformational change in the 
receptor, which translocates to the nucleus, binds as homodimer to specific 
DNA sequences termed estrogen response elements (ERE) and regulates the 
transcription of multiple target genes. The domain architecture of the ER 
includes N-terminal hormone-independent transactivation domain (AF1), a 
highly conserved DNA-binding domain that mediates specific recognition of 
ERE, a hinge domain that separates the DNA-binding domain from the 
ligand-binding domain (LBD), a LBD that contains the hormone binding 
pocket, and a second transactivation domain (AF2) in the C-terminus that is 
activated in response to ligand binding (Figure 9) (Nilsson S. et al. 2001). 
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Figure 9: The domain structures of ERα and ERβ, including some of the known 
phosphorylation sites involved in ligand-independent regulation. (Adapted from Wikipedia). 
 
 
Below is shown the structure and the location of the ERE relative to the coding 
region and the promoter of three prototypic estrogen-induced genes.  
 
 
• TFF1 / pS2 gene 
Trefoil factor 1 is encoded in humans by the TFF1gene (also called pS2 
gene). 
This gene and two other related trefoil family member genes are found in 
a cluster on chromosome 21 (Gött P. at al.1997). 
They encode for three stable secretory proteins expressed in gastro-
intestinal mucosa. Their functions are not defined, but they may protect the 
mucosa from insults, stabilize the mucus layer, and affect healing of the 
epithelium.  
Estrogen stimulates pS2 gene transcription by interacting with an ERE 
s i te  at the 5'- flanking region of that gene (Figure 10). 
 
 
 
Figure  10:  pS2 gene  structure.    It  is formed by 3  exons  and  an Estrogen Responsive 
Element at the 5'- flanking region.
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• BCL2 gene 
Bcl-2 (B-cell lymphoma 2) is encoded in humans by  BCL2 gene and is 
localized on chromosome 18. It is member of the Bcl-2 family of regulator 
proteins that regulate cell death by either inducing it or inhibiting apoptosis 
(Tsujimoto Y. et al 1984). Bcl-2 is specifically considered as an important 
anti-apoptotic protein and is thus classified as an oncogene. 
Estrogen stimulates BCL2 gene transcription by interacting with an ERE 
in the second exon of the gene (Figure 11). 
 
 
 
Figure 11:  BCL2  gene  structure. It  is formed by 3  exons  and  an  Estrogen 
Responsive Element in the coding region (II exon) of the gene. 
 
 
 
• CAV1 gene 
Caveolin-1 is a protein that in humans is encoded by the CAV1gene. CAV1 
and CAV2 are located next to each other  on  chromosome  7  and  express 
co-localizing proteins that form a stable hetero- oligomeric complex. 
The scaffolding protein encoded by this gene is the main component of 
the caveolae plasma membranes found  in  most  cell  types.  The protein 
links integrin subunits to the tyrosine kinase FYN, an initiating step in 
coupling integrins to the Ras-ERK1/2 pathway and promoting cell cycle 
progression. The gene is a tumor suppressor gene candidate and a negative 
regulator of the Ras- p42/44 ERK1/2 kinase cascade. 
Estrogen stimulates CAV1 gene transcription by interacting with the 
first ERE at the 5’end of the gene (Figure 12). 
 
 
 
Figure 12:  CAV1  gene  structure. It is composed by 3 exons and the Estrogen Responsive 
Element in the 5'-flanking region of   the gene.
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2.  AIM OF THE STUDY 
 
 
 
Estrogen exposure is a major determinant of the risk of breast cancer 
(James D. Yager and Nancy E. Davidson 2006) and the expression of the 
receptor is indicative of the clinical outcome of breast cancer. 
The modulation of estrogen signaling remains the mainstay of breast cancer 
treatment for the majority of breast cancers classified as ER-positive (Shang Y. 
2007). Several strategies for inhibiting the estrogen axis in breast cancer exist, 
including: selective ER modulators ( S E R M )  such as tamoxifen and 
raloxifene, which act as selective tissue-specific antagonists of ER in the 
breast (Shang Y. 2006).   However, unfortunately in breast cancer, long term 
SERM therapy causes the development of acquired resistance (Sengupta S. and 
Jordan VC. 2008). More information about the transcriptional m e c h a n i s m s  
u s e d  b y  e s t rogen  may facilitate the understanding and the use of its 
modulators. 
 
 
The specific objectives of this study are: 1. the analysis of the dynamic 
changes of epigenetic marks induced by estrogen; 2. the identification of the 
players involved : 3. the dissection of the mechanism leading to the formation 
of chromatin domains associated with active transcription. 
 
We have used a s  c e l l u l a r  m o d e l  MCF-7 cells, a breast cancer cell 
line, expressing the receptor alpha and responsive to the estrogens. 
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3. MATERIAL AND METHODS 
 
 
 
3.1. Cells, treatment and transfections 
 
Human breast cancer MCF-7 cells were grown at 37°C in 5% CO2 in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with phenol 
red, L-glutamine (2 mM), insulin (10 µg/ml), hydrocortisone (3.75 ng/ml), 
and 10% fetal bovine serum (FBS, South America origin, Brazil, Invitrogen, 
Rockville, MD, USA). Cells were incubated with fresh  medium  every  3  
days.  To evaluate  the  effect  of  Estrogen challenge, cells were grown in 
phenol red-free DMEM containing 10% dextran– charcoal-stripped FBS for 
1 to 3 days, before being challenged with 50 nM Estrogen for different 
times according to the experimental needs. 
For experiment with N-Acetyl-Cysteine, it was used at final 
concentration of 50 mM for 30 min. 
To obtain DNMT3a knock down with siRNA, cells were transiently 
transfected, using a Neon® Transfection System, with siRNA L-006672-01-
0005 (Dharmacon) in medium without serum to a final concentration  of  10  
nM  and  incubation  was continued for 48 h. Scrambled RNA, at the same 
concentration, was used as negative control. To determine the recovery of 
DNMT3a activity in knock down experiments with siRNAs, we used 
DNMT3a full-length cDNA from ADDGENE Plasmid #25328. 
To obtain LSD1 dominant negative expression, the cells were transiently 
transfected, using a Neon® Transfection System, with LSD1 full-length 
cDNA and LSD1 dominat negative (ala) were inserted into the CMV 
3xFLAG, Sigma-Aldrich, St. Louis, MO, USA), in medium without serum 
and incubation was continued for 48 h as previously published (Ambrosio et 
al. 2013). 
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3.2. RNA extraction and qRT-PCR and qPCR 
 
Total RNA was extracted using Trizol (Gibco/Invitrogen). cDNA was 
synthesized in a 20 µl reaction volume containing 1 µg of total RNA, 100 
units of Superscript III Reverse Transcriptase (Invitrogen), and 2 µl random 
hexamer (20 ng/µl) (Invitrogen). mRNA was reverse-transcribed for 1 h at 
50 °C, and the reaction was heat inactivated for 15 min at 70 °C. The 
products were stored at -20 °C until use. 
Quantitative reverse Transcription Polymerase Chain Reaction (qRT-
PCR) and Quantitative Polymerase Chain Reaction (qPCR) were performed 
three times in six replicates on a 7500 Real Time PCR System (Applied 
Biosystems) using the SYBR Green-detection system  (FS Universal SYBR 
Green MasterRox/Roche Applied Science). The complete list of 
oligonucleotides used is reported in Table 1. 
 
 
3.3. Chromatin Immuno-Precipitation (ChIP) 
Cells were transfected and/or treated as indicated in the legends of the 
figures. The cells (~2.5 x 106 for each antibody) were fixed for 10 min at room 
temperature by adding 1 volume of 2% formaldehyde to a final concentration 
of 1%, the reaction was quenched by the addition of glycine to a final 
concentration of 125 mM. Fixed cells were harvested and the pellet was 
resuspended in 1 ml of Lysis Buffer (10 mM Tris- HCl pH 8.0, 10 mM NaCl, 
0.2 % NP40) containing 1X protease inhibitor cocktail (Roche Applied 
Science). The lysates were sonicated in order to have DNA fragments from 
300 to 600 bp. Sonicated samples were centrifuged and supernatants diluted 
2 fold in the ChIP Buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 
mM Tris- HCl pH 8.0).  An aliquot  (1/10) of sheared chromatin was further 
treated  with proteinase K (4U every 1 x 106 nuclei), extracted with 1 volume 
of phenol/chloroform/isoamyl alcohol (25:24:1) and precipitated in LiCl 0,4 
M/ ethanol 75% to determine DNA concentration and shearing efficiency 
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(input DNA). The ChIP reaction was set up according to the manufacturer’s 
instructions. Briefly, the sheared chromatin was precleared for 2 h with 1 µg of 
non-immune IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 20  
µl  of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology) saturated with 
salmon sperm (1 mg/ml). Precleared chromatin was divided in aliquots and 
incubated at 4 °C for 16 h with 1 µg of the specific antibody (for the codes, 
see below) and non-immune IgG respectively. The immuno-complexes were 
recovered by incubation for 3 h at 4 °C with 20 µl of protein-A/G PLUS 
agarose, beads were washed with wash buffers according to the 
manufacturer’s instructions and immunoprecipitated DNA was recovered 
through phenol/chloroform/isoamyl alcohol extraction and ethanol precipitation 
and redissolved in TE buffer (10 mM Tris-HCl, 1mM EDTA, pH 8,0). 
Samples were subjected to qPCR using the primers indicated in the legend of 
the specific figures; primers sequences are reported in Table 1. 
Real Time-qPCRs were performed using Fast Start Universal SYBR Green 
Master (Rox) (Roche Applied Science) with cycle conditions as follows: 95 °C 
10 min; 40x (95 °C 10 sec, 55 °C 30 sec, 72 °C 30 sec); 72 °C 10 min 
 
 
3.4. Chromosome conformation capture (3C) 
The 3C assay was performed as described previously (Dekker J. et al., 
2002) with minor adaptations. Briefly: The  cells  (2.5  x  106)  were  cross-
linked  in  12  ml  of  PBS  with  1% formaldehyde for 10 min at room 
temperature. The reaction was quenched by the addition of glycine to a final 
concentration of 125 mM. Fixed cells were harvested and the pellet 
resuspended in 1 ml of ice-cold lysis buffer (the same used for ChIP 
experiments). Nuclei were washed with 0.5 ml of restriction enzyme buffer 
(100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1mM Dithioerythritol, pH 
7,5 at 37 °C), centrifuged and resuspended in 100 µl of restriction enzyme 
buffer. SDS was added to a final concentration of 0.1%, and nuclei were 
27	  
	  
incubated at 37 °C for 15 min. Triton X-100 was added to the final 
concentration of 1% to sequester SDS. Digestion was performed with 100 U 
of the restriction enzyme at 37 °C for 16 h. The restriction enzyme was 
inactivated by the addition of SDS to 2% and incubation at 65 °C for 30 min 
The reaction was diluted into 1 ml ligation reaction buffer (66 mM Tris-
HCl, 5 mM MgCl2, 5 mM DTT, 1 mM ATP, pH 7,5) and incubated at 16 °C 
for 18 h with 50 U of T4 DNA Ligase (Roche Applied Science). EDTA (10 
mM) was added to stop the reactions. Samples were treated with Proteinase 
K (200 µg/ml) and incubated for 5 h at 55 °C, and then overnight at 65 °C 
to reverse the formaldehyde crosslinks. The following   day, the   DNA   was   
purified   by   phenol/chloroform/isoamyl   alcohol extraction and ethanol 
precipitation. Samples were redissolved in 20 µl of TE buffer. To prepare a 
control template, we used a pool of plasmids containing an equimolar 
amount of the CAV1and BCL2 inserts spanning the genomic regions of 
interest. Five micrograms of plasmid DNA were digested with AVAII or 
Bam HI in 50 µl of 1x buffer for 8 h at 37 °C and then ligated in 20 µl with 
5 U of T4 Ligase at 16 °C for 4 h. The efficiency of digestion at the end of 
3C treatment was quantified by real time PCR, amplifying a fragment 
spanning two AVAII (uncut) in different 3C DNA preparations. Primer 
sequences are reported in Table 1. PCR were performed using FastStart Taq 
DNA Polymerase (Roche Applied Science) with cycle conditions as 
follows: 
CAV1 oligo 8-2 (Prenested): 95 °C 5 min; 5x (95 °C 45 sec, 60 °C 30 sec, 
72 °C 30 sec); 25x (95 °C 45 sec, 58 °C 30 sec, 72 °C 30 sec); 72 °C 10 min 
CAV1 oligo 8-2 (Nested): 95 °C 5 min; 5x (95 °C 45 sec, 62 °C 30 sec, 72 
 °C 35 sec); 
35x (95 °C 45 sec, 60 °C 30 sec, 72 °C 35 sec); 72 °C 10 min 
PCR products were run on1.5% agarose gels, stained with ethidium bromide 
and quantified with the imageJ program (Rasband WS, ImageJ, National 
Institutes of Health,  Bethesda,   Maryland,   USA,   http:   
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//rsb.info.nih.gov/ij/).   The   amplified fragments at the end of the procedure 
were verified by DNA sequence analysis. 
 
 
3.5. Antibodies  
ERa ab32063 (Abcam); H3K4me2 ab32356 (Abcam); H3K4me3 ab1012 
(Abcam); H3K9me2 ab1220 (Abcam); H3K9me3 ab8898 (Abcam); Total 
H3 ab1791 (Abcam); OGG1 sc-33181 (Santa Cruz Biotechnology); LSD1 
ab17721 (Abcam); DNMT3a ab2850 (Abcam); TET1 GTX124207 
(Genetex); TDG sc-292440 (Santa Cruz Biotechnology); XPG sc-13563 
(Santa Cruz Biotechnology); XPC sc-74411 (Santa Cruz  Biotechnology);  
Normal  rabbit  IgG  sc-2027  (Santa  Cruz  Biotechnology); Normal 
mouse IgG sc-2025 (Santa Cruz Biotechnology). 
 
 
3.6. Ligation-dependent Probe Amplification (LPA) 
The LPA assay was performed as described previously (Jan P. Schouten et 
al., 2002) with minor adaptations. Briefly:2µgof DNA samples were digest 
with FpG enzyme (New England Biolabs) for 1 h at 37°C and 5 min at 98°C. 
As control the not digest samples was added the storage buffer of FpG. Then, 
KCL 5x buffer (KCl 750mM, Tris pH 8.0 50mM,EDTA 5mM) and strand 
specifc probes were added to the samples (digest and not digest) and heated for 
1 min at 95°C and then incubated for 16 h at 60°C. 
Ligation of annealed oligonucleotides was performed by diluting the 
samples to 60µl with dilution buffer (2.6 mM MgCl2, 5 mM Tris–HCl pH 8.5, 
0.013% non-ionic detergents, 0.2 mM NAD) containing 1 U Ligase-65 enzyme 
(MRC Hollad), and incubation for 1h at 56°C. The ligase enzyme was 
inactivated by heating at 98°C for 15 min and ligation products were amplified 
by qPCR. For most experiments, 10 µl of the ligation reaction was added to 25 
µl qPCR buffer. Real Time-qPCRs were performed using FastStart Universal 
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SYBR Green Master (Rox) (Roche Applied Science) with cycle conditions as 
follows: 35 cycles (30 s at 95°C, 30 s at 60°C and 40 s min at 72°C). DNA was 
amplified by PCR using primers listed in the Table 1. 
 
 
3.7. Oxidative Bisulfite (OxoBisulfite) 
The  Oxidative  Bisulfite  assay  was  performed  as  described  previously  
(Michael J Booth, et al. 2013) with a mirror adatpion. Briefly: 1µg of DNA 
samples were denatureted in NaOH 0,05 mM at 37°C for 15 min and oxidated 
with 1µl ofPotassium Perruthenate (KRuO4, Sigma) in ice for 1 h, vortexing 
every 15 min. As control, KRuO4 solvent was added to the samples. The 
oxidative and not oxidative samples were undergoes   bisulfite conversion 
(EZ DNA Methylation-GoldTM  Kit, Zymo Research)with cycle conditions as 
follows: 10 min. at 98°C, 4 h at 53°C. 
DNA was amplified by PCR using primers listed in the Table 1 using 
HotStratTaq DNA polymerase (Qiagen) with cycle conditions as follows: 
35 cycles (1 min. at 95°C, 1 min. at 50°C and 1 min at 72°C). 
 
 
3.8. Statistical analysis 
All data are presented as mean ± standard deviation in at least three 
experiments in triplicate  (n≥9).  Statistical  significance  between  groups  
was  determined  using Student’s t test (matched pairs test or unmatched 
test were used as indicated in figure legends).  
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Table 1 
 
 PRIMERS FOR mRNA LOCUS 
mRNA Fw 5’-CCAGACAGAGACGTGTACAGT-3’ pS2 / TFF1 
mRNA Rev 5’-ATTCACACTCCTCTTCTGGA-3’ pS2 / TFF1 
mRNA Fw 5’-GTGGTGGAGGAGCTCTTCAG-3’ BCL2 
mRNA Rev 5’-CAAACTGAGCAGAGTCTTCAG-3’ BCL2 
mRNA Fw 5’-GCAGACGAGCTGAGCGAGAAGC-3’ CAV1 
mRNA Rev 5’-GAATAGACACGGCTGATGCACTG-3’ CAV1 
18S Fw 5’-GCGCTACACTGACTGGCTC-3’ h18S 
18S Rev 5’-CATCCAATCGGTAGTAGCGAC-3’ h18S 
 PRIMERS FOR ChIP LOCUS 
ChIP ERE Fw 5’-CTAGACGGAATGGGCTTCAT-3’ pS2 / TFF1 
ChIP ERE Rev 5’-TCTGAGAGGCCCTCCCGCCAG-3’ pS2 / TFF1 
ChIP PolyA Fw 5’-CTACTCACTGCGGATGCCCCAG-3’ pS2 / TFF1 
ChIP PolyA Rev 5’-GCTTCTGTATCCCTCCTCTGCTG-3’ pS2 / TFF1 
ChIP II Intron Fw 5’-CCTTTTTATACGATGGGTTCTGA-3’ pS2 / TFF1 
ChIP II Intron Rev 5’-CGGCCGTGACTCTGTGTAA-3’ pS2 / TFF1 
ChIP ERE Fw 5’-CATTATAAGCTGTCGCAGAG-3’ BCL2 
ChIP ERE Rev 5’-GAGGGTCAGGTGGACCACAG-3’ BCL2 
ChIP PolyA Fw 5’-AGTAAATGTGCCCAGCCTCT-3’ BCL2 
ChIP PolyA Rev 5’-TAGGGATGGTTCTCTGTTGC-3’ BCL2 
ChIP ERE Fw 5’-GGATCTTAGATAAAGCTGGAAGG-3’ CAV1 
ChIP ERE Rev 5’-GATCTCGCAGAGGACACCACAC-3’ CAV1 
ChIP PolyA Fw 5’-GATGTGATTGCAGAACCA-3’ CAV1 
ChIP PolyA Rev 5’-CAACAGCTTCAAAGAGTG-3’ CAV1 
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 PRIMERS FOR 3C LOCUS 
OLIGO 1 (Prenested) 5’-CACGGACACTGGATCTTGACTAT-3’ BCL2 
OLIGO 1 (Nested) 5’-CCCCTTCCTCTTGCTGGTATC-3’ BCL2 
OLIGO 2 (Prenested) 5’-CTTCTTGCCCTTCTGATGGTTG-3’ BCL2 
OLIGO 2 (Nested) 5’-TATGCGCGTGGGAGGTGT-3’ BCL2 
OLIGO 3 (Prenested) 5’-AATCCTCGGCTGTTCCCTGTTCAC-3’ BCL2 
OLIGO 3 (Nested) 5’-TCTGCCTTCCCCATTCAACTATTA-3’ BCL2 
OLIGO 4 (Prenested) 5’-CGACGACTTCTCCCGCCGCTACC-3’ BCL2 
OLIGO 4 (Nested) 5’-GGACGGGGTGAACTGGGGGAGGAT-3’ BCL2 
OLIGO 1 (Prenested) 5’-CTGGGCGGGGAGGTGAAGAG-3’ CAV1 
OLIGO 1 (Nested) 5’-GAAGAGAAGCCAGGAATGTTTTAT-3’ CAV1 
OLIGO 2 (Prenested) 5’-ACGGGAACGCGAAACAGGTGAAGC-3’ CAV1 
OLIGO 2 (Nested) 5’-CCGGGAGAAGCCTGCGGCTGC-3’ CAV1 
OLIGO 3 (Prenested) 5’-CCTTGGGACGGTGAGATG-3’ CAV1 
OLIGO 3 (Nested) 5’-CGTATTTTCTTTGTCTTTAGTCCT-3’ CAV1 
OLIGO 4 (Prenested) 5’-CAGAGTTTTGTGGGTTTGATGTGT-3’ CAV1 
OLIGO 4 (Nested) 5’-GAGGCATACATTGTTTTTGGTTTT-3’ CAV1 
OLIGO 5 (Prenested) 5’-CAGGAAGACTGGAAGAGGCA-3’ CAV1 
OLIGO 5 (Nested) 5’-TGCCTCCTCCCCCATCTT-3’ CAV1 
OLIGO 6 (Prenested) 5’-GAGACCATTACCCCCCACAAA-3’ CAV1 
OLIGO 6 (Nested) 5’-CACAGACTCTGACACATAAACACCTG-3’ CAV1 
OLIGO 7 (Prenested) 5’-GAGGCAATACCAAGGTTCATCATC-3’ CAV1 
OLIGO 7 (Nested) 5’-AAGTTGGGTGTGAGTGGATTTAAAG-3’ CAV1 
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 PRIMERS FOR LPA LOCUS 
ERE LPOMINUS 5’- 
GGGTTCCCTAAGGGTTGGAcCACTGCAGAAGTG 
ATTCATAGTGAGAGATGGCC-3’ 
pS2 / TFF1 
ERE RPOMINUS 5’- 
GGAAAAAGGCTTGGCCGTGACAACAGTGGCTC 
ACGGGGTgTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
ERE LPOPLUS 5’- 
GGGTTCCCTAAGGGTTGGAcACCCCGTGAGCCA 
CTGTTGTCACGGCCAAGCCTTTTTCC-3’ 
pS2 / TFF1 
ERE LPOPLUS 5’- 
GGGTTCCCTAAGGGTTGGAcACCCCGTGAGCCA 
CTGTTGTCACGGCCAAGCCTTTTTCC-3’ 
pS2 / TFF1 
ERE RPOPLUS 5’- 
GGCCATCTCTCACTATGAATCACTTCTGCAGTG 
gTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
INTRONLPOPLUS 5’- 
GGGTTCCCTAAGGGTTGGAcCAAAAGCAGGTG 
GAGAGTAACTCAGGGTGGCAGGGCCCCC-3’ 
pS2 / TFF1 
INTRONRPOPLUS 5’- 
GGAGACCTTCGAGAAGTGCGACGAGGAGGGG 
GCTgTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
INTRONLPOMINUS 5’- 
GGGTTCCCTAAGGGTTGGAcAGCCCCCTCCTCG 
TCGCACTTCTCGAAGGTCTCC-3’ 
pS2 / TFF1 
INTRONRPOMINUS 5’- 
GGGGGCCCTGCCACCCTGAGTTACTCTCCACCT 
GCTTTTGgTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
TATALPOPLUS 5’- 
GGGTTCCCTAAGGGTTGGAcTAACGCTCTTTAA 
GCAAACAGAGCCTGCCCTATAAAATCC-3’ 
pS2 / TFF1 
TATARPOPLUS 5’- 
GGGGCTCGGGCGGCCTCTCATCCCTGACTCGG 
GGTCgTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
TATALPOMINUS 5’- 
GGGTTCCCTAAGGGTTGGAcGACCCCGAGTCAG 
GGATGAGAGGCCGCCCGAGCCCC-3’ 
 
pS2 / TFF1 
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TATA RPOMINUS 5’- 
GGATTTTATAGGGCAGGCTCTGTTTGCTTAAAG 
AGCGTTAgTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
CnGLPOPLUS 5’- 
GGGTTCCCTAAGGGTTGGAcTTCCCCCTGCAAG 
GTCACGGTGGCCACCCCGTGAGCCACT-3’ 
pS2 / TFF1 
CnGRPOPLUS 5’- 
GTTGTCACGGCCAAGCCTTTTTCCGGCCATCTC 
TCACTATgTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
CnGLPOMINUS 5’- 
GGGTTCCCTAAGGGTTGGAcATAGTGAGAGAT 
GGCCGGAAAAAGGCTTGGCCGTGACAACA-3’ 
pS2 / TFF1 
CnGRPOMINUS 5’- 
GTGGCTCACGGGGTGGCCACCGTGACCTTGCA 
GGGGGAAgTCTAGATTGGATCTTGCTGGCAC-3’ 
pS2 / TFF1 
Universal LPA Fw 5’-GGGTTCCCTAAGGGTTGGA-3’ pS2 / TFF1 
Universal LPA Rw 5’-GTGCCAGCAAGATCCAATCTAGA-3’ pS2 / TFF1 
 PRIMERS FOR OXIDATIVE BISULFITE LOCUS 
ERE bis Minus Rw 5’-TAAACTTCATAAACTCCTTCCCTT-3’ pS2 / TFF1 
ERE bis Minus Fw 5’-GGTTTTATTTATATTTGAGAGGTTTTTT-3’ pS2 / TFF1 
ERE BIS plus Fw 5’-ATGGGTTTTATGAGTTTTTTTT-3’ pS2 / TFF1 
ERE BIS plus Rw 5’-AAAATCTCCTCCAACCTAACCTTAA-3’ pS2 / TFF1 
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4. Results 
 
 
4.1. Screening human promoter array for ER, OGG1, LSD1  
      and topoisomerase II sites induced by estrogen 
 
To isolate and identify DNA regions recruiting, upon estrogen 
stimulation, estrogen  receptor, RNA polymerase II, 8-oxoguanine DNA 
glycosylase (OGG1) and topoisomerase IIβ (Topo IIβ), we have 
immunoprecipitated the chromatin derived from estrogen stimulated cells 
(50 nM for 45 min) with specific antibodies  to  estrogen  receptor  a  
(ERα),  the  lysine specific  demethylase  (LSD1), OGG1 and Topo IIβ. 
DNA fragments immunoprecipitated were used as probe against arrays of 
human promoters (Affymetrix, human promoter 1.0 R array). These arrays 
interrogate regions proximal to transcription start sites and contain probes 
covering 59 percent of CpG islands annotated by UCSC in NCBI human 
genome assembly (Build 34). Each promoter region spans approximately 
from 7.5 kb upstream to 2.45 kb downstream of 5’transcription start sites. 
We obtained several combinations of positive genomic sites depending 
on the antibodies used for immunoprecipitation. We decided to further analyze 
regions that were bound simultaneously by the estrogen receptor, RNA 
polymerase II, OGG1 and Topo IIβ , upon estrogen stimulation. We further 
refined this class of DNA regions by identifying sites, where the LSD1 signal 
was present also in the absence of estrogens. 
We compared these regions (ER-OGG1- Topo Iiβ) with annotated sites  
of  the  estrogen  receptor occupancy and found a significant overlap 
(Figure 13). We have further analyzed and validated several genomic sites 
reported in Figure13. 
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Figure 13: Stringency of the selection (fold increase between E2 treated and untreated). 
Screening human promoter array for ERa, OGG1 LSD1 and TopoisomeraseII sites induced by 
Estrogen. The cells were immunoprecipitated with specific antibody after Estrogen stimulation 
(50nM for 45 min.). DNA fragments immunoprecipitated were used as probe against arrays of 
human promoters (Affymetrix, human promoter 1.0 R array). The data can be accessed 
through this link http://www.genecore.embl.de/affydata/Affymetrix/ENRI). 
 
 
 
4.2. Validation of estrogen induced genes isolated by    
       the promoter array screening 
To validate the genomic regions isolated from  the  promoter  array  
screening reported in Figure 13, we identified 3 genes located in the 
surrounding area where ER was bound and analyzed their expression in the 
presence or absence of estrogens. 
We have first analyzed mRNA levels after estrogen stimulation (Figure 14). 
MCF-7 cells were hormone-starved for 3 days and then treated with Estrogen 
(E2). Total RNA was extracted and reverse transcribed into cDNA and then 
amplified with specific primers of the specific genes examined. The results 
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indicate that estrogen induced cyclic mRNA expression with a peak after 30 
min of stimulation and a second peak of expression that remains stable over 
time (Figure 14). 
 
 
 
 
 
 
Figure 14: Estrogen induced cyclic mRNA expression of genes target. 
Total RNA was prepared from MCF7 hormone-starved or stimulated with 50 nM of Estrogen 
for 30, 60, 120, 240 minutes until 18h and analyzed by qPCR with specific primers (Tablet1) to 
pS2, BCL2 and CAV1 mRNA normalized to 18S RNA levels. The statistical analysis derived 
from at least 3 experiments in triplicate (n≥9; Mean±SD). *p <0.01 (matched pairs t test) 
compared to E2-unstimulated sample, **p<0.01 (matched pairs t test) comparing 30 to 60 min. 
of E2 exposure.  
 
 
 
4.3. Identification of gene regions, where selectively ER 
      accumulates upon estrogen stimulation 
 
 
First, we analyzed by ChIP the actual occupancy of the estrogen 
receptor at the predicted regions by the use of specific oligonucleotides 
(Figure 15a). Figure 14a shows also the location of the putative ERE 
sites relative to the transcription start sites. In some cases, the putative 
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ERE sequence is located at the 5’, in other cases in exons or introns. 
 
 
 
Figure 15a: Schematic representation of studied genes (pS2 – BCL2 – CAV1 genes). 
 
 
Figure 15b shows that active receptor upon estrogen stimulation is rapidly 
recruited to the ERE at 30 - 45 min. This recruitment is not stable, but we 
observe a reduction at 
60 min with a stabilization at 120 min after E2. We have also found that 
other regions of the genes bind estrogen receptor: the 3’ end PolyA addition 
site.  Moreover, the binding of the receptor oscillates at the 3’ end PolyA 
site during E2 stimulation as that found at the ERE, suggesting that the 2 
regions are synchronized or probably interact. 
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Figure 15b: Estrogen induced accumulation of ERa at Estrogen Responsive Elements 
(ERE) and PolyA sequence of genes target.  
qChIP analysis of E2 dependent occupancy of ERa at ERE / PolyA of pS2 – BCL2 - CAV1 
genes. MCF7 cells were stimulated with 50 nM of E2 for 15, 30, 45, 60 and 120 minutes. The 
chromatin was immunoprecipitated with antibodies directed against ERa. The black, 
horizontal, line indicates the percent of input from a control ChIP (Ab: non immune serum). 
The statistical analysis derived from at least 3 experiments in triplicate (n≥9; Mean±SD). *p 
<0.01 (matched pairs t test) compared to E2-unstimulated sample; **p<0.01 (matched pairs t 
test) comparing 45 to 60 min.  
 
 
4.4. A common histone H3 methylation code at the ERE and 
   PolyA chromatin regions induced by estrogens 
 
 
Estrogens induce the transcription of several genes. Some genes are 
induced de novo, others are already transcriptionally active and  the  
hormone  super-induce them. We have determined the histone code changes 
induced by the hormone in both types of genes by analyzing the H3 histone 
methylation code of the lysine 9 and 4 on ERE and PolyA chromatin regions 
of pS2 (induced by E2), CAV1 and BCL2 (super-induced by E2) genes. 
In pS2 ERE and PolyA regions, we find that estrogen induces an early 
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demethylation of the H3k9me3-me2 at  30  and  60  min  and  methylation  
at  45 min (Figure 16a / 16b). At the ERE region, H3k4me2 increases at 15 
min and remains high up to 45 min, whereas H3k4m3 increases at 45 min 
(Figure 16c). At the PolyA region we observe an increase of H3k4me3 at 15 
and 45 min, whereas the H3k4me2 increases only at 45 min (Figure 16d). 
 
 
 
 
Figure 16: Methylation-demethylation cycles of histone H3K4/K9 induced by E2  on pS2 
ERE-PolyA chromatin. MCF7 cells were serum starved and exposed to 50 nM E2 at the 
indicated times (0, 15, 30, 45 and 120 min). qChIP was carried out using specific antibodies 
recognizing H3K4me3, H3K4me2, H3K9me3 and H3K9me2. A, B. H3K9me2 and H3K9me3 
occupancy at pS2ERE and PolyA. C, D. H3K4me2 and H3K4me3 occupancy at pS2ERE 
and PolyA. E, F. TotalH3 occupancy at pS2ERE and PolyA. G. H3K9me2 and H3K9me3 
occupancy at pS2Intron. H. H3K4me2 and H3K4me3 occupancy at pS2Intron. I. TotalH3 
occupancy at pS2Intron. These data were normalized to total H3 histone. The statistical 
analysis derived from at least 3 experiments in triplicate (n ≥9; Mean±SD). *p <0.01 (matched 
pairs t test) compared to E2-unstimulated sample, **p<0.01 (matched pairs t test) comparing 15 
to 30 min. of E2 exposure. 
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In pS2 second  i ntron,  the  methylation  changes  are less  pronounced  
(Figure 16g / 16h). 
In CAV1 ERE and PolyA regions, we find that estrogen induced an early 
demethylation selectively of the H3k9me3 at 30 min and re-methylation at 
45 min, whereas H3K9me2 was methylated at 30 min at ERE and at 45 
min at PolyA (Figure 17a / 17b). H3k4me3-me2 increase at 15 min and 45 
min and decrease at 30 min  (Figure 17c / 17d).  
 
 
 
Figure 17: Methylation-demethylation cycles of histone H3K4/K9 induced by E2  on 
CAV1 ERE-PolyA chromatin. MCF7 cells were serum starved and exposed to 50 nM E2 at 
the indicated times (0, 15, 30, 45 and 120 min). qChIP was carried out using specific 
antibodies recognizing H3K4me3, H3K4me2, H3K9me3 and H3K9me2. A, B. H3K9me2 and 
H3K9me3 occupancy at CAV1ERE and PolyA.  C, D. H3K4me2 and H3K4me3 occupancy at 
CAV1ERE and PolyA. E, F. TotalH3 occupancy at CAV1ERE and PolyA. These data were 
normalized to total H3 histone. The statistical analysis derived from at least 3 experiments in 
triplicate (n ≥9; Mean±SD). *p <0.01 (matched pairs t test) compared to E2-unstimulated 
sample, **p<0.01 (matched pairs t test) comparing 15 to 30 min. of E2 exposure.
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In BCL2 ERE region, we find that estrogen induces an early increase only of the 
H3k9me3 at 15-45 min and 60 min, whereas H3K9me3-me2 are demethylated at 30 
min and re-methylated at 45min on PolyA (Figure 18a /18b). H3k4me2 increases at 30 
min at ERE region and at 45 min at PolyA site, w h i l e  H3K4me3 levels do not 
change (Figure 18c / 18d). 
 
 
 
 
 
Figure 18: Methylation-demethylation cycles of histone H3K4/K9 induced by E2  on 
BCL2 ERE-PolyA chromatin. MCF7 cells were serum starved and exposed to 50 nM E2 at 
the indicated times (0, 15, 30, 45 and 120 min). qChIP was carried out using specific 
antibodies recognizing H3K4me3, H3K4me2, H3K9me3 and H3K9me2. A, B. H3K9me2 
and H3K9me3 occupancy at BCL2ERE and PolyA.  C, D. H3K4me2 and H3K4me3 
occupancy at BCL2ERE and PolyA. E, F. TotalH3 occupancy at BCL2ERE and PolyA. 
These data were normalized to total H3 histone. The statistical analysis derived from at least 3 
experiments in triplicate (n ≥9; Mean±SD). *p <0.01 (matched pairs t test) compared to E2-
unstimulated sample, **p<0.01 (matched pairs t test) comparing 30 to 45 min. of E2 exposure.
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Collectively, all the regions ERE and PolyA sites of the estrogen-induced genes 
analyzed, show  discrete  oscillations  of  methylation  and    demethylation  involving 
H3K9 and H3K4. We suggest that the trigger is the demethylation of H3k9me3-
me2. In addition, we note that the location of the ERE (intron or exon) and the basal 
transcriptional state of the gene may modify the intensity of the methylation- 
demethylation changes. 
 
 
4.5. Formation of dynamic chromatin loops is associated   
     with Estrogen-induced transcription 
 
 
The   data   shown   above   indicate   that   estrogens   induce   the   same   
histone modifications in distal segments of target genes, suggesting that 
these regions are functionally synchronized and may be physically 
associated in an unique estrogen- induced domain. 
To identify these putative estrogen-dependent chromatin domains, we 
performed the 3C analysis on fixed chromatin isolated from E2-induced 
cells (see Method). Briefly, fixed chromatin DNA was cleaved with a 
restriction enzyme and ligated under very diluted conditions to favour intra-
molecular interactions. PCR and DNA sequence were then used to identify 
the ligated DNA segments. 
Figure 19 shows that specific chromatin domains are cyclically induced 
by estrogen at 15 and 60 min. These domains involve the transcription start 
site and PolyA in BCL2 gene. 
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Figure 19: Formation of dynamic chromatin loops in BCL2 during early E2-
induced transcription.  
3C analysis of BCL2 chromatin MCF7 cells exposed to 50nM of E2 for various periods of 
time. A. Schematic presentation of gene and sites of Bam H1 enzyme. All the combinations of 
primers indicated, were performed on ligated chromatin. B. Time course of chromatin looping 
during E2 induction. 3C analysis was carried out as described in Methods. All 3C-fragments 
have been sequenced. 
 
 
 
 
Figure 20: Formation of dynamic chromatin loops in CAV1 during early E2-
induced transcription.  
3C analysis of CAV1 chromatin MCF7 cells exposed to 50nM of E2 for various periods of 
time. A. Schematic presentation of gene and sites of AVA II enzyme. All the combinations of 
primers indicated, were performed on ligated chromatin. B. Time course of chromatin looping 
during E2 induction with or without RNAseH. C. Time course of chromatin looping during 
E2 induction in presence of N-acetyl-cysteine (NAC). 3C analysis was carried out as 
described in Methods. All 3C-fragments have been sequenced. 
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Figure 20a shows that estrogen induced chromatin domains in CAV1 gene 
at 15 – 45 and 60 min, these domains involve ERE1 and PolyA regions. 
Moreover, chromatin treatment with RNAseH eliminates the domain 
corresponding to the late loop (45-60 min) whereas the early loop is not 
affected. This suggests that the second interaction between these distal 
regions is dependent on a hybrid DNA / RNA (Figure 20a). 
We   have   also   investigated   if   local   DNA   oxidation   induced   by   
histone demethylation (Perillo et al., 2008) is necessary for loop formation. In 
fact, pretreatment of cells with the aspecific antioxidant, N-acetyl-cysteine 
(NAC), inhibits the PolyA-ERE  loop  formation  (Figure20b)  receptor  
recruitment and  mRNA accumulation (Figure 21). 
 
 
 
 
 
Figure 21: NAC inhibits E2-dependent CAV1 mRNA expression and ERa binding 
to ERE region.  
MCF7 cells were pretreated with 50mM of NAC and exposed to 50nM of E2 for various 
periods of time. A. Inhibition of Transcription induced by Estrogen. B. ChIP analysis of E2-
dependent ERa binding to ERE and PolyA. The statistical analysis derived from at least 3 
experiments in triplicate (n ≥9; Mean±SD). *p <0.01 (matched pairs t test) compared to E2-
unstimulated sample. 
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These data indicate that estrogen induced a chromatin loop between 
ERE and PolyA regions and the physical association of these 2 sites may 
explain the same type of histone modifications. The enzyme that drives in vivo 
H3_K9 me2 demethylation induced by estrogens is LSD1 (KDM1) (Perillo 
et al., 2008; ref). To demonstrate that LSD1 is involved in loop formation, we 
transfected the cells with a dominant negative expression vector of LSD1 
(LSD1 ala). The expression of this mutant inhibits the recruitment of the E2  
receptor  to  the  ERE  and  prevents  histone  H3-K9me2 methylation 
changes (Ambrosio et al, 2013). Expression of this mutant inhibited also, 
H3k9me2 demethylation induced by E2 (Figure 22b/c). The expression of this 
LSD1 variant inhibited also E2-induced chromatin loop (Figure 22a) and 
inhibited CAV1 mRNA expression (Figure 22d). 
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Figure 22: Expression of LSD1 dominant negative inhibits estrogen-induced 
transcription.  
MCF7 cells were transfected with LSD1 wt or LSD1 ala expression vectors and exposed to 
50nM of E2 for various periods of time. A. Expression of LSD1 dominant negative inhibits 
E2-dependent chromatin loop in CAV1. B, C. Expression of LSD1 dominant negative 
prevents histone H3-k9me2 methylation changes induced by E2. D. Expression of LSD1 
dominant negative inhibits E2-dependent transcription. E. LSD1 protein expression. The 
statistical analysis derived from at least 3 experiments in triplicate (n ≥9; Mean±SD). *p <0.01 
(matched pairs t test) compared to E2-unstimulated sample. 
 
 
4.6. Recruitment of base (BER) or nucleotide (NER)    
       excision repair enzymes to the ERE-PolyA chromatin   
       regions induced by Estrogen 
Transcription is associated with a burst of DNA oxidation dependent 
from histone demethylation (Perillo B. et al 2008). Oxidized guanine (8-oxo-
dG) is recognized by OGG1 (Amente S. et al. 2010). In addition, it was 
recently reported that NER enzymes are essential for the formation of 
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chromatin loops and DNA de-methylation induced by retinoic acid at the 
target genes (Le May N. et al., 2012). Together these data suggest that both 
BER and NER enzymes participate to the formation of chromatin loops 
induced by nuclear hormones and are essential for the correct repair of 
DNA oxidation lesions. Therefore, we analyzed the recruitment of OGG1 
(BER), XPC and XPG (NER) at the ERE and PolyA chromatin regions after 
E2 induction. 
ChIP analysis shows a rapid OGG1 recruitment with two peaks (15 and 
45-60 min) suggesting that also DNA oxidation and repair at the ERE and 
PolyA sites, undergo the same cycle observed in histone demethylation and 
loop formation. In addition, we notice important and selective differences in 
the recruitment of XPC and XPG: XPC is recruited earlier at the ERE than 
XPG (15 min versus 45 min), while at the PolyA both XPC and XPG are 
recruited with the same timing (Figure 23). 
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Figure 23: Estrogen induced BER and NER cycles on genes target. MCF7 cells were 
serum starved and exposed to 50 nM E2 at the indicated times (0, 15, 30, 45 and 60 min). 
qChIP was carried out using specific antibodies recognizing OGG1, XPC and XPG. A, D, 
G. OGG1 occupancy at ERE and PolyA. B, E, H. XPC occupancy at ERE and PolyA. C, F, 
I. XPG occupancy at ERE and PolyA. The statistical analysis derived from at least 3 
experiments in triplicate (n ≥9; Mean±SD). *p <0.01 (matched pairs t test) compared to E2-
unstimulated sample. 
 
 
These data suggest a hierarchy in the recruitment of BER and NER and 
between different types of NER enzymes. In fact, we find cyclic OGG1 
recruitment at ERE region at 15 and 45 – 60 min, whereas XPC and XPG 
increase only at 30 min. Also, at the ERE, XPC is recruited before XPG (30 
min), which is recruited mainly at the PolyA at 30 min. This information is 
relevant, because XPC is part of the Global Genome NER that recognizes 
lesions caused by the distortion of the double helix. This suggests that the 
oxidative or apurinic site is recognized by XPC independently of the 
presence of stalled PolII in the transcription coupled repair (TCR) 
recognized by XPG. E2 and presumably other nuclear hormones induce 
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DNA oxidation, loop formation assisted by BER and NER enzymes, 
which are essential for the proper repair and looping of DNA. 
 
 
 
 
4.7. Estrogen induces strand specific oxidation and repair 
 
 
The data shown above, indicate that E2 induces a burst of DNA oxidation 
and selective and ordered recruitment o f  BER and NER enzymes to the 
ERE and PolyA sites of target genes. To directly document the DNA 
oxidative lesions and to monitor site-specific repair, we mapped precisely 
oxodGs by using the Ligation Proximity Amplification (LPA) technique. 
Briefly: ligation and amplification of contiguous oligonucleotides 
terminating at the specific G under study, are inhibited if this G is oxidized 
and eliminated by glycosylase. Inhibition of PCR, before or after the G-
glycosylase treatment, provides the information on the oxidation state of the 
specific G. The cells were treated with E2 50nM for various periods of time, 
the genomic DNA was extracted and treated with the 8-oxoGuanine DNA 
Glycosylase from E.coli (FpG) to generate apurinic sites from 8-oxoG. We 
have measured 4 CpG at the ERE, TATA, Intron regions of pS2 gene (- 399, 
- 20 from TSS). 
Figure 24 shows the sensitivity of the technique. Control cells were treated 
with and without hydrogen peroxide (H2O2), which is a strong oxidant. DNA 
was extracted, treated with or without FpG, and, after ligation, was amplified 
with strand specific probes. We find that without FpG treatment, there are small 
differences in the efficiency of PCR between the genomic DNA extracted from 
control and H2O2-treated cells, whereas FpG treatment increases this 
difference by 4  fold.  Note  that  H2O2    oxidizes  both strand (- and + 
strand, template and non-template strand, respectively) with the same 
efficiency. 
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Figure 24: LPA assay control. 
MCF7 cells were treated with 1mM of H2O2. DNA was extracted, treated with the 
DNA glycosylase from E.coli (FPG) to generate apurinic sites, where 8-oxoG was 
present. The nick generated by FPG cannot support ligation and PCR of contiguous 
primers. The statistical analysis derived from at least 3 experiments in triplicate (n ≥9; 
Mean±SD). 
 
 
Figure 25 shows the results of LPA on 2 Gs located at the ERE, TATA 
and intron of pS2 gene in cells exposed for various times at E2. At the ERE 
region, we find that 2 Gs are selectively repaired on the (-) and (+) strands: the 
first (top panels) shows oxidation at 5min and repair at 15 min at the (+) strand 
and oxidation at 15 min and repair at 30 min at the (-) strand. The C (indicated 
as ERE II) is oxidized with perfect complementary timing at the (+) and (-) 
strands, respectively. The C at the TATAA, instead is oxidized at 0 (when 
PolII is inefficiently active), repaired at 30 min on the (+) strand and at 15 
min on the (-) strand. In all cases, the oxidation of Gs measured with LPA 
mirrors the H3 histone methylation–demethylation cycles and the timing of 
loop formation induced by E2. 
These data indicate a precise order in timing and space of oxidation and 
repair induced by E2 and highlight the symmetry of cycles of methylation and 
oxidation that govern the assembly of the transcription machine induced by the 
hormones. 
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Figure 25: Strand specific DNA oxidation induced by Estrogen.  
MCF7 cells were treated with 50nM of E2 at the indicated times (0, 15, 30, 45 and 60 min). 
DNA was extracted, treated with the DNA glycosylase from E.coli (FPG) to generate apurinic 
sites, where 8-oxoG was present. We have measured 4 CpG at the ERE, TATA, Intron 
regions of pS2 gene (- 399, - 20 from TSS). The statistical analysis derived from at least 3 
experiments in triplicate (n ≥9; Mean±SD). 
 
 
 
 
 
 
4.8.Recruitment of DNMT3a to the ERE-PolyA chromatin 
regions induced by Estrogen regulates the DNA oxidation 
levels 
 
 
DNA oxidation involves not only G but also C. In fact C can be 
oxidized only when methylated in vivo. It has been reported that estrogens 
induce cycles of the CpG methylation within the pS2 promoter through 
recruitment of DNMTs enzymes (Metivier et al.2003). The DNA 
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methyltransferase enzyme, DNMT3a, cooperates with Tymidine DNA 
Glycosilase that recognizes G/T mismatches in DNA (Ya-Qiang Li et al. 
2007). 
To dissect the  role  of  DNMT3a  in  oxidation  and  more  general,  
transcription induced by estrogen, we determined the recruitment of DNMT3a at 
ERE and PolyA of pS2 gene. ChIP analysis shows that DNMT3a recruitment 
peaks at 30min and its cycle at the ERE appears complementary to that of OGG1 
(Figure 26). 
To define a possible role of DNMT3a in DNA oxidation induced by E2, 
we silenced DNMT3a and measured OGG1 recruitment at regulatory regions of pS2 
gene. Figure 24 shows that depletion of DNMT3a increases OGG1 density at 
the ERE region basally and in E2-induced cells. 
 
 
 
 
Figure 26: Estrogen induces recruitment of DNMT3a at the ERE and PolyA sites of 
target genes. 
MCF7 cells were serum starved and exposed to 50 nM E2 at the indicated times (0, 15, 30, 45 
and 60 min). qChIP was carried out using specific antibodies recognizing DNMT3a.   
A.DNMt3a   occupancy at   ERE   and   PolyA   of   pS2.   B.DNMT3a occupancy at ERE 
and PolyA of BCL2. C. DNMT3a occupancy at ERE and PolyA of CAV1. The statistical 
analysis derived from at least 3 experiments in triplicate (n ≥9; Mean±SD). *p <0.01 
(matched pairs t test) compared to E2-unstimulated sample. 
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Strikingly, the recruitment of OGG1 was reduced at the PolyA site, 
suggesting that the ERE and PolyA sites were not physically contiguous in 
the absence of DNMT3a. This corresponds to inhibition of E2-induced 
mRNA accumulation in DNMT3a- depleted cells. 
 
 
 
 
 
Figure 27: DNMT3a silencing enhances OGG1 recruitment at ERE region and reduces 
pS2 transcription. 
MCF7 cells were transfected with siRNA DNMT3a, serum starved and exposed 
to 50 nM E2  at the indicated times (0 and 30). A. qChIP analysis shows OGG1 occupancy at 
ERE of pS2. B.DNMT3a silencing inhibits transcription induced by estrogen. C. Western blot 
analysis shows silencing of DNMT3a. 
The statistical analysis derived from at least 3 experiments in triplicate (n ≥9; Mean±SD). 
*p <0.01 (matched pairs t test) compared to E2-unstimulated  sample, ++ p<0.01 (matched 
pairs t test) comparing 0 to 30 min. of E2 exposure. 
 
We conclude that DNMT3a is important for productive transcription 
induced by estrogens and its activity is necessary to control oxidation and 
OGG1 recruitment. The loss of OGG1 at the 3’ end is compatible with the 
absence of 5’-3’ loop connecting the ERE to the PolyA sites.  Increase of 
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OGG1 in DNMT3a depleted cells may indicate that repair of the oxidative 
lesions is not efficient (Ya-Qiang Li, et al. 2007). 
We also analyzed the recruitment of TDG and TET1 enzymes. 
 
TET1 can induce oxidation of methyl-cytosine in hydroxyl-methyl-
Cytosine, Formyl-Cytosine and Carboxy-Cytosine that can also be directly 
excised by TDG (Rahul M. Kohli & Yi Zhang, 2013). 
ChIP analysis shows that estrogen induced TDG recruitment at 15 and 45 
min at the PolyA site of pS2, CAV1 and BCL2 gene, whereas TDG was 
recruited 15 min at ERE of BCL2. Instead, TET1 increased at 15 – 30 - 45 
min at all the analyzed regions (Figure 28). 
 
Figure 28: Estrogen induces recruitment of TDG and TET1 at the ERE and PolyA sites 
of target genes. 
MCF7 cells were serum starved and exposed to 50 nM E2 at the indicated times (0, 15, 30, 
45, 60and 120 min). qChIP was carried out using specific antibodies recognizing TDG and 
TET1. A, C, E.TDG occupancy at ERE and PolyA of pS2. B, D, F.TET1 occupancy at ERE 
and PolyA of BCL2. The statistical analysis derived from at least 3 experiments in triplicate 
(n ≥9; Mean±SD). *p <0.01 (matched pairs t test) compared to E2-unstimulated sample. 
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4.9. Coordination of C and G oxidation induced by estrogens 
Estrogen induces recruitment of DNMT3a and TET1 to regulate the wave 
of DNA methylation and oxidation. This coordinated recruitment of 
methylation (DNMT3a) and hydroxymethylation (TET1) of cytosine may be 
crucial for repair. In addition, the presence of the TET1 oxidation products 
(5-hmC and 5-formylC) marks active transcription (You, et al. 2014; Neri et 
al. 2015). 
To determine the methylation and oxidation of C induced by estrogens, 
we performed a modified bisulfite assay on ERE region of pS2. 
The use potassium perruthenate (KRuO4) selectively oxidizes 5hmC into 5- 
formyl-cytosine (5fC), which after bisulfite conversion is read as uracil in 
the sequence. Therefore, in genomic DNA from estrogen-treated cells, we 
have measured methyl and hydroxyl-Cat the ERE of pS2 gene. 
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Figure 29: Estrogen induced specific CpG methylation 
MCF7 cells were treated with 50nM of E2 at the indicated times (0, 15, 30, 45 and 60 min). 
DNA was extracted, treated with sodium bisulfite. We analyzed 5 CG in position: - 399, - 387, - 
369, - 354, - 301 from TSS of pS2 gene. The statistical analysis derived from at least 2 
experiments in duplicate. 
 
 
We analyzed a fragment of 200 bp on ERE containing 5 CpG. 
 
Figure 29 shows that   4 of 5 CpG display a difference in methylation, 
which appears to be strand specific: the non-template (+) strand is more 
methylated. In addition, all 5 CpG   analyzed   display a methylation peak at 
45 min, which overlaps with the peak of histone H3K9 methylation (Figure 
16). 
Note a sharp methylation peak of CG -399 on template (-) strand at 15 
min (Figure 29a), and demethylation of CG - 369 at the same strand at 60 min 
(figure 29c). Figure 30 shows that the 5 CpG have a different levels of C  
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hydroxylmethylation. In fact, CG - 399 has a peak of C hydroxylmethylation 
at 15 and 30 min on template (-) strand and then returns to baseline at 45-60 
min. 
 
 
 
Figure 30:  specific  C hydroxymethylation induced by estrogen at the pS2 ERE. 
MCF7 cells were treated with 50nM of E2 at the indicated times (0, 15, 30, 45 and 60 min). 
DNA was extracted, treated with the Potassium Perruthenate (KRuO4) to generate difference 
between methyl-cytosine and hydroxymethyl-cytosine, where was present. Then, the samples 
were treated with sodium bisulfite. We analyzed 5 CG in position: - 399, - 387, - 369, -354, -301 
from TSS of pS2 gene. The statistical analysis derived from at least 2 experiments in duplicate. 
 
 
We conclude that estrogens induce a sharp C hydroxyl-methylation peak 
at specific Cs in a strand-specific manner. It is worth mention that CpG 
hydroxymethylation timing is dissociated from the DNA methylation. 
58	  
	  
5. DISCUSSION 
 
 
Transcription induced by estrogen is associated with chromatin 
modification dependent from histone methylation-demethylation cycles.  It 
has been already found that Estrogen induced transcription is driven by 
H3K9me2 demethylation (Perillo et al. 2008). Our data show that estrogens 
induce a common change of the histone code at target genes. In particular, 
we observe demethylation of histone H3K9 in the first 30 min, followed by 
a peak of methylation at 45 min and demethylation at 60 min. Also, H3K4 
is characterized by a cyclical methylation (15 and 45 min) (Figure 15 – 16 -
17). Both methylation the lysines 9  and 4 are stabilized after the first hour 
of induced-transcription, when the transcription become productive. 
Interestingly, this common histone code may change slightly depending on 
the location of the enhancer (intra or inter-gene)) and the status of the basal 
transcription (see ERE BCL2 and PolyA regions in Figure 17). LSD1 
and JMJD2a are the major histone demethylases responsible for histone 
modification induced by estrogen. We find a different timing of the 
recruitment of LSD1 and JMJD2a at the gene locations examined (data not 
shown). LSD1 dominant negative expression in MCF7 inhibits H3K9 
demethylation, mRNA expression and chromatin domains induced by 
estrogen (Figure 21). 
Transcription induced by estrogen  is  associated  also  with  the  
formation  of chromatin loops that display a precise synchronization to 
permit an accurate definition of the 5’ and 3’ borders of the transcription 
unit. 
Pretreatment of cells with NAC inhibits gene transcription, the 
formation of the loop and the receptor binding to enhancer (Figure 20) 
suggesting that oxidation is important for transcription.  It is worth noting  
that  treatment  of  chromatin  with RNaseH prevents the formation of the 
late (45 min) loop but not of the early (15 min) loop, between ERE and 
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PolyA regions. This suggests that hybrid DNA / RNA   (R-Loop) may 
hold together the 5’ and 3’ ends of the genes carrying the receptor only after 
45’ of continuous stimulation with estrogens (Figure 19). 
Histone demethylation  generates  a  burst  of  oxidation (Perillo  et  al.  
2008) that recruits DNA repair enzymes: BER and NER enzymes (Figure 22 
and 25). The initial lesions   are   recognized   by   OGG1 and APE1, which   
display   the   same   oscillations   of demethylation-methylation cycles (15 
and 45-60). Following OGG1, NER are recruited at 30 min. Interestingly, 
XPC is recruited to the enhancer, whereas XPG to the PolyA (Figure 22). 
XPC is part of the Global Genomic NER, which recognizes helix distortions 
regardless of the presence of Pol II. On the other hand, XPG is part of 
Transcription-Coupled NER, which assists the RNA Pol II during recognition 
of the lesion (Gros L. et al., 2002). These data suggest that the ERE and PolyA 
lesions are differently recognized and repaired. OGG1 recognizes the 8-oxo Gs 
detecting a distortion of the helix (Kuznetsova A.A. et al. 2014). This can 
represent a signal for recruitment of XPC (GG-NER) at enhancer and can 
determine a stall of RNA Pol II at the PolyA, which recruits XPG (TC-NER). 
We have evaluated in detail the specific Gs oxidized and repaired. 
We have measured the formation of 8-oxo-guanine (8-oxogG) by LPA 
technique. The data show that estrogens induce oxidation and repair 
differentially at the (-) and (+) strands of the ERE region. In fact, the non-
template strand is oxidized-repaired mainly 5-15min while the template strand 
is oxidized-repaired essentially 15 and 45 min after estrogen stimulation 
(Figure 26). This ordered sequence of oxidation and repair probably reflects 
the structure of the helix across the 25 bp spanning the Gs analyzed. 
Our data shed light also on DNMT3a, which is recruited at the enhancer 
and PolyA sites at 30 min.    DNMT3a is essential for productive  
transcription  induced  by estrogens. We find that DNMT3a silencing increases 
OGG1 recruitment at the ERE in the basal and in the sample stimulated 
with estrogens, while it reduces the OGG1 recruitment at PolyA site. This 
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suggests that the 5’ and 3’ ends are not juxtaposed  as in control cells. The 
changes in methylation and hydroxymethylation of CpG are also associated 
with the recruitment of TET1 and TDG at enhancer and PolyA sites. TET1 
recognizes and modifies the methylcytosine, while TDG recognizes and 
removes a variety of oxydized and deaminated cytosines. TET1 is recruited 15 
– 30 min to the enhancer and 60 min after estrogen stimulation to the PolyA. 
TDG is recruited to the PolyA and enhancer of  BCL2  but  not  to  CAV1  and  
pS2  enhancers.   
 Finally, we analyzed the methylation and hydroxylation status of DNA at 
single strand resolution. Bisulfite analysis shows that template and non-
template strands have a different levels and timing of methylation.   Also, 
hydroxymethylation of specific Cs was induced by estrogens. We note that the 
changes of hydroxymethylation are associated with the timing and the location 
of oxidized Gs, suggesting that the 2 events  (G and C methylation-oxidation) 
are tightly associated. 
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6.CONCLUSION 
 
 
We show periodic oscillations of histone H3 methylation, G oxidation, C 
methylation and hydroxyl-methylation at the enhancer and PolyA addition sites 
after induction of transcription in prototypic estrogen-induced genes. These 
oscillations correlate with formation of chromatin loops that juxtapose the 5’ 
and 3’ ends of the induced genes. BER followed by NER enzymes are 
recruited to the 5’ and 3’ end sites to repair the DNA oxidative lesions and to 
stabilize the 5’ and 3’ borders of the transcriptional units included in the 
loops. At the 5’ and 3’ end sites of the loops, repair of oxidized Gs and  
hydroxymethylated  Cs  proceeds  in  a  strand  specific  fashion. DNA 
methylation by DNMT3a is associated to G and C oxidation and reduces the G 
oxidation levels. This ordered series of localized DNA oxidation and repair are 
essential for productive transcription induced by estrogens. 
We suggest that coupling transcription with methylation and repair enzymes 
is the evolutionary strategy to reduce the mutational burden induced by 
DNA oxidation at the borders of chromatin loops. 
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ABSTRACT
We report that homology-directed repair of a DNA
double-strand break within a single copy Green
Fluorescent Protein (GFP) gene in HeLa cells alters
the methylation pattern at the site of recombination.
DNA methyl transferase (DNMT)1, DNMT3a and two
proteins that regulate methylation, Np95 and
GADD45A, are recruited to the site of repair and
are responsible for selective methylation of the
promoter-distal segment of the repaired DNA. The
initial methylation pattern of the locus is modified in
a transcription-dependent fashion during the 15–20
days following repair, at which time no further
changes in the methylation pattern occur. The vari-
ation in DNA modification generates stable clones
with wide ranges of GFP expression. Collectively,
our data indicate that somatic DNA methylation
follows homologous repair and is subjected to re-
modeling by local transcription in a discrete time
window during and after the damage. We propose
that DNA methylation of repaired genes represents
a DNA damage code and is source of variation of
gene expression.
INTRODUCTION
DNA methylation is a feature of higher eukaryote
genomes. It is thought to help organize large segments
of noncoding DNA in heterochromatin and to contribute
to genome stability (1). DNA methylation is critical
during development in plants and mammals. In somatic
cells, patterns of methylated CpGs are transmitted to
daughter cells with high ﬁdelity (2,3). Aberrant methyla-
tion, both hyper- and hypo-methylation, has been found
in cancer cells (4).
There are two patterns of DNA methylation: (i) Stable
methylation, which is the basis of imprinting, is inherited
in a sex-speciﬁc fashion and is invariant among individuals
and cell types. Loss or modiﬁcation of stable methylation
results in signiﬁcant phenotypic and genetic alterations.
(ii) Unstable or metastable methylation, which is
variable among individuals and cell types.
Despite numerous analyses of the methylation proﬁles
of single chromosomes, the regulation of DNA methyla-
tion is largely unknown. Somatic DNA methylation is
associated with gene silencing and heterochromatin for-
mation and is neither sequence- nor cell-speciﬁc.
We are investigating the nature of somatic DNA methy-
lation and its link to gene silencing during neoplastic pro-
gression (5,6). Since formation of DNA double-strand
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breaks (DSBs) and activation of DNA damage
checkpoints may precede genomic instability (7) and
DNA methylation and gene instability appear to be
linked in cancer (8), we speculated that DNA methylation
was associated with DNA damage and repair.
We previously reported that homology-directed repair
(HDR) modiﬁes the methylation pattern of the repaired
DNA (9). This was demonstrated using a system pion-
eered by Jasin (10,11), in which recombination between
partial duplications of a chromosomal Green
Fluorescent Protein (GFP) gene is initiated by a speciﬁc
DSB in one copy. The unique DSB is generated by
cleavage with the meganuclease I-SceI, which does not
cleave the eukaryotic genome. The DSB is repeatedly
formed and repaired, until the I-SceI site is lost by hom-
ologous or nonhomologous repair or depletion of I-SceI
enzyme. Recombination products can be detected by
direct analysis of the DNA ﬂanking the DSB or by the
appearance of functional GFP (9).
Two cell types are generated after recombination: clones
expressing high levels of GFP and clones expressing low
levels of GFP, referred to as H and L clones, respectively.
Relative to the parental gene, the repaired GFP is
hypomethylated in H clones and hypermethylated in
L clones. The altered methylation pattern is largely
restricted to a segment just 30 to the DSB.
Hypermethylation of this tract signiﬁcantly reduces tran-
scription, although it is 2000 bp distant from the strong
cytomegalovirus (CMV) promoter that drives GFP ex-
pression (9,12). The ratio between L and H clones is
1–2 or 1–4, depending on the insertion site of the GFP
reporter. These experiments were performed in mouse em-
bryonic (ES) or human cancer (Hela) cells. HDR-induced
methylation was dependent on DNA methyl transferase I
(DNMT1). Furthermore, methylation induced by HDR
was independent of the methylation status of the convert-
ing template (9). These data, taken together, argue for a
cause–effect relationship between DNA damage-repair
and DNA methylation.
The link between DNA damage, repair and de novo
methylation has been conﬁrmed by other studies (13–15).
We also note that genome wide surveys show that imprinted
sites are historical recombination hot spots, reinforcing our
conclusion and that of other workers, that DNA methyla-
tion marks the site of DNA recombination (16,17).
We report here that methylation induced by HDR is
inﬂuenced by recruitment of Np95 and GADD45a to
the DSB and that DNMT3a is also active at the DSB.
We also show that methylation is reduced by transcription
of the repaired region.
MATERIALS AND METHODS
Cell culture, transfections and plasmids
HeLa cells lines were cultured at 37C in 5% CO2 in
RPMI medium supplemented with 10% fetal bovine
serum (Invitrogen), 1% penicillin-streptomycin, and
2mM glutamine.
HeLa-pDRGFP cells were obtained by transfection of
HeLa cells with the pDRGFP plasmid. Brieﬂy: 5 106
cells were seeded in a 100mm dish and transfected with
lipofectamine as recommended by the manufacturer
(Invitrogen) with 2mg of linearized pDRGFP plasmid and
selected in the presence of puromycin (2micrograms/ml).
Four clones were isolated and expanded, the remaining
clones were screened for single pDRGFP insertion by
quantitative Polymerase Chain Reaction (qPCR) [support-
ing information in (9)] and pooled (200 clones with a
pDRGFP copy number ranging from 0.8 to 1,2 copies/
genome). Clone 3 is the same clone 3 described in (9);
clone 4 is a subclone of the clone 2 assayed also by
Southern Blot (9). 106 puromycin-resistant cells were transi-
ent transfected by electroporation with 2.5mg of plasmid
DNAs and/or small interfering RNA (siRNA) (200nM) as
indicated in the Figures. After transfection cells were seeded
at 3 105 cells per 60mm dish, 24h post-transfection, cells
were treated and harvested as described in ﬁgures. Pools of
cloneswere generated in three independent transfections and
frozen in aliquots. Transient transfections with I-SceI were
carried at different times of culture after the primary trans-
fection. Transfection efﬁciency was measured by assaying
b-galactosidase activity of an included pSVbGal vector
(Promega). Normalization by ﬂuorescent-activated cell
sorter (FACS) was performed using antibodies to b-gal or
pCMV-DsRed-Express (Clontech). pEGFP (Clontech) was
used as GFP control vector. The structure of the pDRGFP
and other plasmids are described in the supplementary data
(Suplementary Methods and Supplementary Figure S12).
Nucleic acid extraction and quantitative reverse
Transcription Polymerase Chain Reaction, qPCR and PCR
Total RNA was extracted using Triazol (Gibco/
Invitrogen). Genomic DNA extraction was performed as
described in (9). cDNA was synthesized in a 20ml reaction
volume containing 2 mg of total RNA, four units of
Omniscript Reverse Transcriptase (Qiagen), and 1 ml
random hexamer (20 ng/ml) (Invitrogen). mRNA was
reverse-transcribed for 1 h at 37C, and the reaction was
heat inactivated for 10min at 70C. The products were
stored at 20C until use. Ampliﬁcations were performed
in 20 ml reaction mixture containing 2 ml of synthesized
cDNA product or 0.1 mg of genomic DNA, 2 ml of 10X
PCR buffer, 1.5mM MgCl2, 0.5mM dNTP, 1.25 unit of
Taq polymerase (Roche), and 0.2 mM of each primer on a
TC3000G thermocycler (Bibby Scientiﬁc Italia). The
number of cycles was selected and validated by running
several control reactions and determining the linear range
of the reaction. 15 ml of the PCR products were applied to
a 1.2% agarose gel and visualized by ethidium bromide
staining. Densitometric analysis was performed using a
phosphoimager. Each point was determined in at least
three independent reactions. Quantitative reverse
Transcription Polymerase Chain Reaction (qRT-PCR)
and qPCR were performed three times in six replicates
on a 7500 Real Time-PCR on DNA template (RT-PCR)
System (Applied Biosystems) using the SYBR Green-de-
tection system (FS Universal SYBR Green MasterRox/
Roche Applied Science). The complete list of oligonucleo-
tides is reported in Supplementary Table S1.
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FACS analysis
HeLa-DRGFP cells were harvested and resuspended in
500ml of phosphate buffered saline (PBS) at density of
106 cells/ml. Cell viability was assessed by propidium
iodide (PI) staining. Cytoﬂuorimetric analysis was per-
formed on a 9600 Cyan System (Dako Cytometrix) or
FACScan Flow Cytometer (Becton Dickinson, Franklin
Lakes, NJ, USA). PI positive cells were excluded from the
analysis by gating the PI-negative cells on a FSC-Linear
versus FL2H-Log plot. GFP+ cells were identiﬁed by
using a gate (R1 in Supplementary Figure S3A) on a
FL1H-Log versus Fl2H-Log plot after sample compensa-
tion for FL1 versus FL2 channels. L and H cells were
identiﬁed on FL1H Histogram of the R1-gated cells with
two range-gate, as shown in Figure 1. The same gate was
used for all cytoﬂuorimetric determinations.
Cell cycle analysis was carried out by FACS: 1 106 cells
were resuspended in 1ml of PBS and ﬁxed 10ml of ice-cold
70% ethanol. Afther 3 h, the cells were washed and stained
for 30min at room temperature with 0.1% Triton X100,
0.2mg/ml Dnase-free RnaseA, 20mg/ml PI. Fluorescence
was evalued by FACS and analyzed by ModFit LT 2.0
(Verity Software House, Topsham, ME, USA).
Population comparison was performed using the
Population Comparison module of the FlowJo software
(Tree Star, Inc., Ashland, OR). Difference in ﬂuorescence
intensity (mean) was determined using the matched pairs
Student’s t test.
Bisulﬁte DNA preparation, PCR and sequence analysis
Sodium bisulﬁte analysis was carried out on puriﬁed gen-
omic DNA and on ‘chromatinized’ DNA. The full list of the
buffer formulation is reported in the Supplementary
Methods (Buffers Formulation). Chromatinized DNA was
obtained as follows: 107 cells were ﬁxed at 4C temperature
with 1% formaldehyde for 3min. The reaction was stopped
with glycine to a ﬁnal concentration of 125mM. Nuclei were
isolated and permeabilized by incubating cells for 20min in
Buffer A, 20min in Buffer B and then resuspended in Buffer
C (see Buffers Formulation in Supplementary Methods).
Nuclei or puriﬁed genomic DNA was heat denaturated
(96C for 10min) incubated in a fresh solution containing
5M sodium bisulﬁte and 20mM hydroquinone and
incubated at 37C for 18h. The cross-link was reversed,
and proteins were digested with proteinase K (50mg/ml
at 55C for 2h, and then at 65C overnight). DNA was
puriﬁed using a Wizard genomic puriﬁcation kit
(Promega), and then disulphonated by incubation for
15min with NaOH to a ﬁnal concentration of 0.3M,
neutralized with ammonium acetate to a ﬁnal concentration
of 3M, and puriﬁed by ethanol precipitation. DNA
was ampliﬁed by PCR using primers, listed in the
Supplementary Table S1, using Taq polymerase, which is
able to copy deoxyuridine, cloned in TOPO TA vector
(Invitrogen), and sequenced with the M13 reverse primers.
Chromatin Immunoprecipitation
Cells were transfected and/or treated as indicated in the
legends of the ﬁgures. The cells (1 106) were ﬁxed by
adding formaldehyde directly in the culture medium to a
ﬁnal concentration of 1% for 10min at room temperature
and washed twice using ice cold PBS containing 1
protease inhibitor cocktail (Roche Applied Science) and
1mM Phenylmethylsulfonyl Fluoride (PMSF). Fixed cells
were harvested and the pellet was resuspended in 200 ml of
sodium dodecyl sulphate Lysis Buffer (ChIP Assay Kit/
Upstate). After 10min incubation on ice, the lysates were
sonicated to shear DNA to 300-and 1000-bp fragments.
Sonicated samples were centrifuged and supernatants
duluted 10-fold in the ChIP Dilution Buffer (ChIP
Assay Kit/Upstate). An aliquot (1/50) of sheared chroma-
tin was further treated with proteinase K, phenol/chloro-
form extracted and precipitated to determine DNA
concentration and shearing efﬁciency (input DNA). The
chromatin immunoprecipitation (ChIP) reaction was set
up according to the manufacturer’s instructions. Brieﬂy,
the sheared chromatin was precleard for 2 h with 20 ml of
protein-A or protein-G agarose (Upstate) and 2 mg of
nonimmune IgG (New England Biolabs). Precleared chro-
matin was divided in two aliquots and incubated at 4C
for 16 h with 20 ml of protein-A/G agarose and 2 mg of the
speciﬁc antibody (Np95, generated and characterizated by
IM Bonapace; RNA Pol II from Upstate cat. # 05-623;
DNMT1, DNMT3a and DNMT3b from Abcam, cat. #
ab-13537, ab-2850 and ab-2851, respectively) and nonim-
mune IgG respectively. Agarose beads were washed with
wash buffers according to the manufacturer’s instructions
and immunoprecipitated DNA was recovered and sub-
jected to qPCR using the primers indicated in the legend
of the speciﬁc ﬁgures and in Supplementary Table S1.
Methylated DNA immunoprecipitation
Cells were transfected and/or treated as indicated in the
legend of the ﬁgures. The cells (5 106) were harvested
and genomic DNA extracted as described above. Ten
micrograms of total genomic DNA were digested in
200 ml for 16 h with restriction endonuclease mix contain-
ing 30 U each of Eco RI, Bam HI, Hind III, XbaI, Sal I
(Roche Applied Science), phenol/chloroform extracted,
ethanol precipitated and resuspended in 50 ml of Tris-
HCl/EDTA buffer (10mM Tris-HCl pH 7.8, 1mM
EDTA) (TE) buffer. An aliquot (1/10) of digested DNA
was used as input to determine the DNA concentration
and digestion efﬁciency. Methylated DNA immunopre-
cipitation (MEDIP) was performed essentially as
described (18) except that 2mg of antibody speciﬁc for
5mC (Abcam cat. # ab-124936) were used to precipitate
methylated DNA from 5 mg of total genomic DNA. H19
and UE2B were used to control in each experiment the
efﬁciency of 5mC immunoprecipitation; the CpG island
located to 50 end of human beta-actin was used as undam-
aged transcribed DNA gene control.
Statistical analysis
All data are presented as mean±standard deviation in at
least three experiments in triplicate (n 9). Statistical sig-
niﬁcance between groups was determined using Student’s
t test (matched pairs test or unmatched test were used as
indicated in ﬁgure legends). Hierarchical clustering
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Figure 1. HDR generates high and low GFP-expressing clones. (A) Structure of the integrated tester DRGFP plasmid before and after repair. The
structure of the plasmid (10,11) has been veriﬁed by sequence analysis. The boxes and arrows with different grayscales represent the structural
elements of the integrated nonrecombinant (upper) and recombinant (lower) plasmid. The conversion of the I-SceI to BcgI restriction site marks the
gene conversion event driven by the copy of GFP gene located at the 30 end of DRGFP (cassette II). (B) Generation and accumulation of high (H)
and low (L) expressor cells following homologous repair. Kinetics of L and H clones accumulation. Cells containing a single copy of DRGFP (clones
3 and 4, see ‘Materials and Methods’ section) or pool of clones (shown here), characterized as described in ‘Materials and Methods’ section, were
transfected with I-SceI and subjected to FACS analysis at the times indicated. GFP positive (GFP+) cells were identiﬁed by the R1 gate
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(Ward’s criterion) analysis was performed using the JMP
Statistical DiscoveryTM software by SAS, Statistical
Analysis Software. Sequence analysis and alignments
were performed using MegAlign software (a module of
the Lasergene Software Suite for sequence analysis by
DNASTAR) for MacOSX.
RESULTS
Repair-induced methylation at the 30 end of a DSB
The system we use to study DNA methylation induced by
damage and repair relies on a single-copy integrated
plasmid (DRGFP), which contains two inactive versions
of GFP. Introduction of a DSB in one copy of the gene
(cassette I) by expressing the nuclease I-SceI, generates a
functional GFP only in cells in which the second copy of
GFP (cassette II) provides the template to repair the DSB
(10,11) (Figure 1A). Homologous repair both in pools and
single clones generates cells expressing low (L clones) or
high levels (H clones) of GFP. These clones can be tracked
by FACS analysis, using bivariate plots and gating
strategies.
The integrated DRGFP undergoes several cycles of
cutting and resealing until the I-SceI site is lost by nonhom-
ologous end joining (NHEJ) or homology-dependent
repair (HDR). We deﬁned the time window of HDR by
monitoring the appearance of recombinant GFP DNA in
the population of cells transiently expressing I-SceI. We
also measured the levels of I-SceI protein in transfected
cells to estimate the period of enzymatic cleavage.
Supplementary Figure S1A shows that the levels of recom-
binantGFP reached a plateau 3 days after transfection with
I-SceI. The enzyme accumulated between 12 and 24 h and
progressively disappeared 48–72 h after transfection. The
estimated half-life of I-SceI protein was between 12 and
24 h (Supplementary Figure S1B).
Having established that the bulk of repair activity
occurred in 3 days, we monitored the appearance and sta-
bilization of L and H clones during and after HDR (9).
Figure 1B shows the accumulation of L and H cells after
exposure to I-SceI in a pool of HeLa clones as well as in
single insertion clones carrying DRGFP inserts at differ-
ent loci (see the legend of Figure 1B). Three days after I-
SceI transfection, when HDR was almost complete, L and
H cells accumulated in a 1:1 ratio (Figure 1B). We have
used time-lapse microscopy to monitor GFP appearance
during 30 h after I-SceI induction. The Supplementary
Movie shows the I and II/III cycles (relative to GFP
expression) during repair and the appearance of H and
L cells from single repair events. In the I cycle, H and L
cells are generated; in the II/III cycle (H-H and L-L), the
phenotypes are stably propagated. Eventually, the ratio L/
H cells changes as a function of time, until day 7 when the
L to H ratio stabilized at 1:4 (Figure 1B). No further
change was detected after numerous subsequent
passages, and no new GFP clones appeared (data not
shown). Note that this shift to high GFP-expressing cells
occured after DSB repair, and therefore represents an in-
herited epigenetic process.
The drift toward H clones is detailed in Figure 1C. This
ﬁgure also shows the levels of GFP mRNA as a function
of time after transfection with the I-SceI plasmid. The
changes in GFP mRNA concentrations correlate well
with the ﬂuorescence measurements that reﬂect GFP
expression. We wondered if the time-dependent epigenetic
changes were related to transcription of the GFP gene.
This notion was tested by adding a-amanitin during
repair and following the appearance of L and H clones.
a-Amanitin inhibits translocation of elongating RNA
polymerase II (Pol II) and increases the concentration of
the polymerase on transcribed genes (19).
The pool of DRGFP clones, as well as one clone (Cl4),
was transfected with I-SceI, and after 24 h, exposed to
a-amanitin for 24 h. Five days later (day 7 after I-SceI
transfection), GFP expression was analyzed by
cytoﬂuorimetry. Exposure of the cells to the drug did
not inﬂuence the rate of recombination (Supplementary
Figure S2A). As expected, it signiﬁcantly enriched GFP
chromatin with Pol II molecules (Supplementary Figure
S2B). Figure 2A and Supplementary Figure S3 show that
a-amanitin treatment of pooled cells (or clone 4) shifted
the populations of L and H classes in opposite directions
(see arrows AMA): L and H cells displayed on the
average, lower or higher ﬂuorescence intensity, respect-
ively. Exposure to a-amanitin 6 days before transfection
with I-SceI or 6 days after did not affect the distribution
of L and H clones (Figure 2A and Supplementary
Figure S3A). Statistical analysis of the data of 28 inde-
pendent experiments in which a-amanitin was added dur-
ing recombination to pools or single clones indicates that
the results are reproducible (Figure 2B and Supplementary
Figure S3B). Quantitative analysis of GFP ﬂuorescence in
H and L cells exposed to a-amanitin during repair reveals
that the fraction of L cells increased and that the GFP
expression in these cells was markedly reduced.
Conversely, the H cell fraction decreased, but the intensity
of the ﬂuorescent signal in these cells was enhanced
(Figure 2B). We hypothesize that transient stalling of
Pol II induced by a-amanitin during repair, increased
GFP methylation, yielding higher numbers of L clones
and reducing the fraction of H clones.
We therefore asked if a-amanitin altered the DNAmethy-
lation proﬁle of the repaired GFP gene. Clones 3 and 4 were
Figure 1. Continued
(see Supplementary Figure S3A) on a bivariate plot (FL1H versus FL2H) after I-SceI transfection. A representative experiment, displaying the L and
H cells is shown. Each panel shows (i) the days after I-SceI transfection; (ii) total GFP positive cells (%); (iii) the range gates used to discriminate H
and L cells; (iv) the ratio L/H, which reached a plateau 7–14 days after I-SceI transfection. Panel (C): the number (percent of total GFP+ cells, left)
and the ﬂuorescence intensity (mean, center) of H and L cells derived from clones (not shown here) or pool of clones, based on at least ﬁve
independent experiments. After 7–14 days, the L/H ratio and the intensity of L and H peaks stabilize. CMV–EGFP transfected cells, as control lines,
display a single ﬂuorescence peak (9). The right panel shows the relative levels, normalized to 18 S RNA, of nonrecombinant (UnRec) and recom-
binant (Rec) GFP mRNA after I-SceI transfection (see ‘Materials and Methods’ section).
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Figure 2. Synchronization of transcription by a-amanitin during repair ampliﬁes and consolidates L and H clones. (A) Cytoﬂuorimetric analysis.
Cells were exposed to a-amanitin before, during or after I-SceI transfection as indicated on the top of each panel. A pool of HeLa DRGFP cells or a
clone carrying a single insert were transfected with I-SceI expression vector, and 24 h later, an aliquot was exposed for 24 h to 2.5 mM a-amanitin.
The cells were washed and cultured in normal medium for 5 days, when FACS analysis was carried out (day 7 after I-SceI transfection). The
ﬂuorescence plots of GFP positive cells (overlay of the histograms of RI gates, see Supplementary Figure S3) are shown. L and H represent the range
gates to identify high and low expressors, respectively. The arrows, indicated by AMA, represent the shift of the mean ﬂuorescence after a-amanitin
treatment. Differences between treatments were tested for statistical signiﬁcance using Student’s matched pairs t test: *P< 0.001, **P< 0.05. Under
these conditions, a-amanitin did not affect cell survival or growth rate. Five days after 24-h 2.5 -mM a-amanitin treatment, transcription of several
housekeeping genes was similar to untreated controls. The changes of GFP expression following the short treatment(s) with the drug during repair
(24 h after I-SceI transfection) were stable for up 3 months in culture. (B) Statistical analysis derived from 28 independent experiments, in which
DRGFP cells were exposed to a-amanitin during repair as indicated above. The panel shows the statistical signiﬁcance of the means (±SD).
Differences between treatments were tested for statistical signiﬁcance using Student’s matched pairs t test: *P< 0.001, **P< 0.05.
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treated with a-amanitin (6–24 h), sorted 5 days later into H
and L clones and analyzed by MEDIP assay with speciﬁc
antibodies against 5-methylcytidine (anti-5mC) with primers
indicated in Figure 3A. Figure 3B shows that anti-5mC rec-
ognizes the region 30 to the I-SceI site in the repaired GFP.
As predicted, the frequency of 5mC was higher in L clones
than in H clones. Consistent with GFP expression proﬁles
shown in Figure 2, a-amanitin increased the levels of 5mC in
the L clones. The changes in 5mC levels were speciﬁc to the
recombinant GFP segment, since the methylation status of
the b-actin 50 CpG island did not change (data not shown).
Additionally, the methylation status of H19-DMR
(Differentially Methylated Region), or UBE2B gene
(NC_000005.9), used as positive and negative controls of
MEDIP immunoprecipitation, did not change after a-
amanitin (Figure 3C). To visualize directly the methylation
status of the repaired segment of GFP in a-amanitin-
exposed cells, we performed bisulﬁte analysis of the GFP
gene in treated cells (Supplementary Figure S4). The
repaired GFP gene just 30 to the DSB was selectively
hypermethylated or hypomethylated in L and H cells, re-
spectively. Treatment with a-amanitin for 6 or 24h
accentuated these alterations of methylation: L clones
became more methylated and H clones less methylated
than untreated cells. Longer exposure (48h) to a-amanitin
did not signiﬁcantly alter the methylation pattern seen at 6
or 24h (see the legend of Supplementary Figure S4).
To explore further the local chromatin changes induced
by methylation and the effects of a-amanitin on this
process, we analyzed sites on the GFP gene that were pro-
tected from bisulﬁte conversion. Brieﬂy, chromatin of L
and H cells was ﬁxed with formaldehyde, heat denatured
and exposed to bisulﬁte. By probing GFP DNA, we can
detect speciﬁc DNA segments protected, most likely by
bound proteins, that block C to T conversion by bisulﬁte
or by structures preventing single-strand formation
(Figure 3D). The protected segment of GFP corresponds
to the region containing the methylated sites at the 30 end
of I-SceI, as shown in Supplementary Figure S4. We
found no protected areas in the H clones, whether or
not they were treated with a-amanitin. Exposure to
a-amanitin enhanced protection against bisulﬁte in most
of the regions found to have increased DNA methylation
after repair (compare Figures 3 and Supplementary
Figure S4).
We propose that stalled RNA polymerase during repair
favors the recruitment of enzymes that methylate the
repaired DNA, consolidating the methylation of L clones.
This event occurs only during repair because stalling Pol II
before or after DSB repair does not modify GFP methyla-
tion and expression.
Transcription modiﬁes methylation of the repaired gene
The a-amanitin experiments suggest that the transcription
machinery plays a major role in repair-induced methyla-
tion. We chose to inhibit transcription in a different
fashion, by treating the cells with actinomycin-D (Act-D)
for 6 h after repair. In contrast to a-amanitin, Act-D
depletes RNA polymerase II from chromatin (20).
We were unable to use Act-D during repair, owing to
inhibition of HR by the drug (data not shown). After
repair, 6 h exposure to Act-D did not alter DNA
replication or HDR (legend of Figure 4). Under these
conditions, the treatment with Act-D prevented the accu-
mulation of H clones at 2 and 4 days later (5 and 7 days
after I-SceI transfection), although the number of GFP+
cells was similar in all samples (9.5%), and the recom-
bination frequency was unaltered (Figure 4B and data not
shown). This ﬁnding suggests that the conversion of L to
H cells after repair requires transcription (Figure 4B). To
conﬁrm the effectiveness of Act-D and to explore the
mechanism of inhibition of H cell formation, we
measured mRNA levels of several genes. Speciﬁcally, we
analyzed the accumulation of stable and unstable RNAs:
(i) recombinant (Rec) and nonrecombinant (UnRec) GFP;
(ii) c-Myc (0.5–1 h half-life) (21); (iii) b-actin (8–12 h half-
life; data not shown) (22); and (iv) 18 S ribosomal RNA,
10 and 96 h after Act-D treatment. Figure 4C (left panel)
shows the expected reduction in c-Myc, unRec and Rec
mRNA levels 10 h after Act-D treatment (day 3). Rec
mRNA was more stable than unRec mRNA. However,
96 h after Act-D exposure (day 7), UnRec and c-Myc
mRNA concentrations returned to control values,
whereas Rec mRNA levels remained lower than controls
(Figure 4C, middle panel). Depletion of Pol II after Act-D
exposure and the restauration of GFP-bound Pol II were
conﬁrmed by ChIP analysis of Un-Rec and Rec DNA
(Figure 4C, rightmost panel). After 12–15 days, the
increase of methylation and the inhibition of transcription
of the GFP gene, induced by Act-D, progressively dis-
appeared. Resumption of transcription promoted methy-
lation loss during this period and accumulation of H cells
from L cells (Figure 4B). These changes occurred only
2–3 weeks after the repair and were speciﬁc to repaired
DNA because Act-D did not change the expression of un-
damaged GFP and, when administered 27–30 days after
repair, did not modify GFP methylation (Supplementary
Figure S5). We note that the time window of Act-D
responsiveness (3–15 days after exposure to I-SceI) corres-
ponds to the time required to stabilize the L/H cell ratio
(Figure 1), suggesting that stabilization of the DNA–chro-
matin domain induced by HDR occurs in this interval.
Collectively, these data indicate that after repair transcrip-
tion converts a fraction of L to H cells by favoring loss of
methylation.
Hierarchical clustering analysis of GFP methylation in
repaired clones links discrete methylation states to gene
expression variation
The data shown above indicate that the original methyla-
tion proﬁles induced by HDR are remodeled in a tran-
scription-dependent fashion during the ﬁrst 15 days after
repair. The pattern eventually stabilizes, locking the epi-
genetic status of the repaired DNA in each cell (see
Supplementary Movie, cycles I and II/III). By using hier-
archical clustering analysis of bisulﬁte-treated GFP mol-
ecules before and after HDR, we were able to track and
identify the original methylation proﬁles (epialleles)
induced by HDR and modiﬁed during transcription. We
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Figure 3. DNA methylation and chromatin modiﬁcations of the DSB region in cells exposed to a-amanitin during repair. (A) Location of Bcg, Rec1
and Rec2 primers, which recognize selectively recombinant GFP. Cassette I and II refer to Figure 1. (B) MEDIP with anti-5mC antibodies of
recombinant GFP gene. Clones 3 and 4 were treated with a-amanitin for 24 h as described in Figure 2 and sorted 5 days after I-SceI as described in
‘Materials and Methods’ section. Content of 5mC is higher in L cells compared with H cells, a-amanitin also increases the levels of 5mC in L cells
and lowers them in H cells. The results are similar for both amplicons (REC1 and REC2). All data derive from three independent experiments
performed in triplicate (mean±SD; n=9). Differences between treatments were tested for statistical signiﬁcance using Student’s matched pairs
t test: *P< 0.01 as compared with the each control (a-amanitin treated versus untreated cells). Differences between cells (H versus L) were tested for
statistical signiﬁcance using Student’s t test: P< 0.01. (C) MEDIP analysis of the methylated H19 DMR (differentially methylated region) and the
hypomethylated UBE2B genes in clone 3 and 4, treated with a-amanitin, as indicated in B. Longer exposure (48 h) to a-amanitin did not signiﬁcantly
alter the methylation pattern seen at 6 or 24 h assayed by bisulﬁte analysis (Supplementary Figure S4). (D) Bisulﬁte protection of GFP chromatin in
L and H cells. Clone 4 cells were treated with a-amanitin for 6 or 24 h after transfection and sorted as indicated in ‘Materials and Methods’ section.
Chromatin was puriﬁed as described in ‘Materials and Methods’ section, denatured and treated with sodium bisulﬁte. DNA was extracted, ampliﬁed,
cloned in TOPO TA vector and sequenced. The ampliﬁed segment corresponds to the Rec1 region and primers were designed for the bisulﬁte-
converted (+) strand. The boxes represent stretches of nonconverted dCs present in the GFP sequence. At least 15 independent GFP molecules were
analyzed for each treatment, including cells not exposed to I-SceI (C). The numbers with the grayscale boxes represent the percentage of the
molecules protected from bisulﬁte conversion in the regions indicated by boxes. The scale shows the coordinates of the GFP sequence relative to
the DSB (indicated as 0 or I-SceI/BcgI site).
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Figure 4. Transient exposure of recombinant cells to Actinomycin D increases methylation of the repaired gene. Panel (A) shows the time frame of
actinomycin-D (Act-D) treatment and the assays performed. The cells were transfected with I-SceI expression vector and 72 h later were exposed to
Act-D (0.05mg/ml) for 6 h. Act-D did not induce detectable modiﬁcations of the cell cycle by PI analysis (G1 50±2 versus 50±3; S 23±1.2 versus
25±1.6; G2/M 27±1.6 versus 25±1.8 in the presence of 6 h Act-D); the cells were viable and RNA polymerase II was depleted from the
chromatin. Five days after the treatment, the recombination frequency, measured by qPCR and GFP transcription were comparable between
treated and untreated cells. The arrows indicate the time window of RNA analysis, MEDIP, FACS and cell sorting, relative to I-SceI transfection.
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also were able to link the methylation states of epialleles to
GFP expression levels, since the bisulﬁte analysis was
carried out on ﬂuorescent-sorted cells. Clones expressing
intermediate levels of GFP (L2 and H2) contain a set of
GFP epialleles originating from a common GFP precursor
segregating in the L fraction. This epiallele precursor in
L cells generates many similar epialleles as a result of
losing methyl groups (Supplementary Figures S6 and
S7). These sites are shared by L2 and H2 clones and are
located in 2 symmetric domains downstream of the DSB,
spanning the length of a nucleosome (150 bp)
(Supplementary Figure S7C and D). The sites are
demethylated by 5-AzadC and methylated by Act-D treat-
ments (Supplementary Figure S7C and D or data not
shown). These data deﬁnitely link gene expression to
speciﬁc methylation states and explain the stochastic ex-
pression of GFP after HDR (see Supplementary Movie).
DNMT3a is transiently recruited to repaired GFP and
stimulates DNA methylation
We previously reported that the hypermethylated L cell
population was not found in a mutant lacking the main-
tenance DNMT1. In contrast, hypermethylation of the
repaired gene was seen in both DNMT3a/ and
DNMT3b/ mutants (9). However, loss of methylation
induced by repair in stable DNMT1 mutant cells may be
the indirect consequence of lack of propagation of methy-
lation in daughter cells by DNMT1. Since large stretches
of DNA are resynthesized during homologous recombin-
ation and are devoid of methylation marks, it is possible
that de novo DNMTs such as DNMT3a and 3 b have a
role during or early after repair, and that DNMT1 may
propagate the methylation marks set by DNMT3a and/or
3 b during replication. To investigate this possibility, we
analyzed the recruitment of DNMT3a and 3 b to the
I-SceI–cleaved chromatin. Figure 5A and B show that
both DNMT3a and DNMT3b were recruited to the
I-SceI site 24 h after the onset of DSB formation and
rapidly disappeared (48 h). We then selectively silenced
DNMT3a and 3 b during repair and analyzed the
distribution of L and H cells. Figure 5C shows that the
yield of L cells was signiﬁcantly reduced and both the
number and GFP ﬂuorescence intensity of H cells
increased when DNMT3a expression was silenced. In
contrast, depletion of DNMT3b did not alter the ratio
of L and H cells (Figure 5C). Expression of wild-type
enzyme in DNMT3a-silenced cells prevented the loss of
L cells. The changes of GFP expression levels were caused
by DNA methylation, since the rescue of L cells by
DNMT3a was prevented by treatment with 5azadC
(Figure 5C).
In conclusion, we propose that DNMT3a helps the for-
mation of hypermethylated clones and DNMT1 propa-
gates these methylation patterns through at least several
generations. This ﬁnding reinforces the notion that main-
tenance and de novo methyl transferases cooperate (23).
Np95 is recruited to repaired GFP and stimulates
DNA methylation
We reported that DNMT1 was required for hyper-
methylation of repaired GFP. We now ask if proteins
that modify DNMT1 activity inﬂuence DNA methylation
at the repaired DSB. We probed for Np95 (also known as
UHRF1 or ICBP90), a protein that binds to DNMT1,
DNMT3a, DNMT3b and PCNA and stimulates methyla-
tion of hemi-methylated DNA (24–26). ChIP analysis of
GFP chromatin from clones 3 and 4 showed that Np95
preferentially accumulated on the repaired chromatin of
the L clones. Treatment with a-amanitin during repair
signiﬁcantly ampliﬁed or decreased Np95 recruitment to
GFP chromatin in L or H cells, respectively (Figure 6A).
Note that the binding of Np95 to H19, UEB2B or b-actin
CpG island chromatin was unaffected by a-amanitin
(Figure 6B and data not shown). Thus, the association
of Np95 with the DSB of GFP DNA appears to be
linked to hypermethylation and reduced GFP expression
in the L cell population.
To test whether Np95 recruitment to recombinant chro-
matin was relevant to repair-induced methylation, we se-
lectively silenced Np95 expression during recombination.
Figure 4. Continued
(B) FACS analysis (a representative of ﬁve independent experiments) was performed as described in Figure 1 at 5, 7 and 12 days after I-SceI
transfection (2, 4 and 9 days after Act-D treatment, respectively). Panel (C) Left. GFP mRNA accumulation assayed by qPCR after Act-D treatment
(3 days after I-SceI transfection and 10 h after Act-D, or 7 days after I-SceI and 96 h after Act-D) normalized to 18 S RNA. Recombinant (Rec) and
nonrecombinant (UnRec) mRNA levels are expressed as percent of untreated levels±SD because the absolute mRNA levels cannot be compared
because of the differences of the efﬁciency of the primers. The same results were obtained normalizing GFP RNA to GAPDH mRNA. Differences
between treatments were tested for statistical signiﬁcance using Student’s matched pairs t test: *P< 0.01 as compared with the each untreated control.
Right. RNA polymerase II recruitment on recombinant and nonrecombinant GFP chromatin after Act-D treatment. ChIP with anti-Pol II large
fragment antibodies of chromatin extracted from Act-D–treated cells 3 days after I-SceI transfection (10 h after Act-D) or 7 days after I-SceI (96 h
after Act-D). *P< 0.01 compared with the each untreated control; **P< 0.01, 3 days compared to 7 days time point; the average of immunopre-
cipitated DNA with a control Ig is reported on the bar graph. (D) GFP mRNA levels and MEDIP assay at day 8 on sorted GFP+ cells. Left:
Recombinant (Rec) and nonrecombinant (UnRec) primers were used to quantify GFP mRNA by qPCR and to measure the contamination of
nonrecombinant GFP negative cells. The values were normalized to GAPDH (white columns) or 18 S (black columns) RNAs. Rec mRNA levels are
shown as percent of the levels found in control cells (I-SceI transfected/Act-D untreated cells); UnRec mRNA levels are expressed as percent of
control (untransfected DRGFP cells) (mean of three experiments in triplicate±SD). *P< 0.01 as compared with untreated control. Right: 5mC
content was carried out on sorted GFP+ cells (H and L) as indicated in panel A. Speciﬁcally, we analyzed the 5mC content of (i) a segment of the
GFP promoter, 1 kb upstream the DSB (oligo b and c, see Supplementary Table S1); (ii) the region 30 to the DSB, which was methylated by HDR;
and (iii) H19 and UE2B genes, as controls of hypermethylated and undermethylated genes, respectively, and to monitor the efﬁciency of MEDIP
assays. The 5mC levels in these regions, except the segment 30 to the DSB, were not modiﬁed by 6 h Act-D treatment (data not shown). 5mC levels
are expressed as percentage of input (mean±SD of three experiments in triplicate); the average of immunoprecipitated DNA with a control Ig is
reported on the bar graph. *P< 0.01 as compared with the each untreated control. Act-D, administered 27, 30 and 35 days after I-SceI for 6 h,
transiently inhibited transcription, but did not change GFP gene methylation.
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Figure 5. DNMT3a and 3b are recruited to the DSB early during repair, but only DNMT3a is necessary for generation of L cells (A and B)
Recruitment of DNMT3a, DNMT3b to the I-SceI chromatin. Cells were transfected with I-SceI and 24 h, 48 h or 7 days later, were ﬁxed, collected,
chromatin-extracted and subjected to ChIP analysis with speciﬁc anti-DNMT3a and DNMT3b antibodies. The speciﬁc primers used to amplify the
GFP cassette I are indicated in (A). Data represent the fraction of immunoprecipitated DNA relative to the input chromatin-DNA present in the
reactions (% of input; mean±SD; n 9); the average of immunoprecipitated DNA with a control Ig is reported on each bar graph. *P< 0.01,
paired t test. (C) Silencing the expression of DNMT3a reduces L cells. Cells were electroporated with the siRNA targeting DNMT3a and DNMT3b
(see ‘Materials and Methods’ section and protocol S1) and analyzed 7 days later, when L and H cells were clearly separated. On the bottom left
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We measured GFP expression, DNA methylation in the
repaired segment and the frequency of recombination.
Figures 6C (left panel) and Supplementary Figure S8
show that silencing of Np95 expression signiﬁcantly
enhanced ﬂuorescence intensity in both the L and H cell
fractions. Np95 depletion did not affect recombination
frequency (Supplementary Figure S8A) but induced loss
of methylation at the 30 end of the repaired GFP gene
(Figure 6C, right panel). Under the same conditions,
Np95 depletion did not modify the methylation status of
b-actin CpG island, or stably methylated gene, H19
(DMR) (see the legend of Figure 6C). Overexpression
of mouse wild-type Np95 reversed the effects of the
silencing and reduced GFP expression (Supplementary
Figure S8B).
Np95 interacts with several proteins involved in chro-
matin remodeling, speciﬁcally those that set repressive
marks on histones, such as SUV39 and EZH2 (27,28).
Indeed, 24 h after DSB induction, the I-SceI chromatin
shows an accumulation of histone repressive (H3K9
m2-m3) and a reduction of positive H3K4 (m2 and m3)
marks, respectively [(13) and data not shown]. To test if
SUV39 and EZH2, which also interact with DNMT1
(27,28), play a role on DNA methylation induced by
damage and repair, we silenced their expression during
repair and determined the distribution of L and H cells.
Knockdown of these proteins did not signiﬁcantly modify
the intensity of the GFP signal in either L or H cells
(Supplementary Figure S9A). Although a modest
decrease in GFP expression in SUV39-depleted cells was
caused by inhibition of recombination (Supplementary
Figure S9C), the levels of GFP methylation were not
modiﬁed in cells in which SUV39 and EZH2 were
silenced (Supplementary Figure S9D).
GADD45a binds DSB and inhibits de novo methylation
induced by HDR
To identify a DNMT1 partner that inhibits DNA methy-
lation during repair and generates H cells, we monitored
GADD45a (G45a) expression and localization after DSB
formation. We recently found that GADD45A binds
hemi-methylated DNA, inhibits DNMT1 in vitro and
in vivo and reduces the fraction of L cells (18), suggesting
that GADD45A promotes loss of methylation on the
repaired DNA (29,30).
We ﬁrst measured GADD45A mRNA levels in cells
exposed to I-SceI or to the DNA-damaging agent,
etoposide. GADD45A mRNA was induced by I-SceI
and decreased to pre-induced levels 48 h after I-SceI trans-
fection (Supplementary Figure S10). We next asked if
GADD45A accumulated on DNA during HDR. ChIP
analysis shows that GADD45A was recruited to GFP
chromatin 48 h after I-SceI expression, conﬁrming a
previous observation (18). Recruitment of GADD45A,
as well as DNMT1 and Pol II, was further stimulated by
a-amanitin (Figure 7A and B). Note that DNMT1 accu-
mulation on MGMT and p16, genes normally methylated
in Hela cells, was not stimulated by I-SceI expression or
a-amanitin (Figure 7A, lower panel).
We next tested the effects of silencing GADD45A on
recombinant DNA methylation. Figure 6C shows that
GADD45A knockdown (Supplementary Figure S11) in-
hibited GFP expression at 2 and 4 days after the damage.
However, although reproducible, this effect, which was
not noted previously (18), was transient; it was statistically
signiﬁcant at day 2 and progressively disappeared at 4
and 7 days after I-SceI expression (Figure 7C and
Supplementary Figure S11 panels A and C). The conse-
quences on GFP expression of GADD45A silencing at
2 days were reversed by co-transfection with a mouse
GADD45A expression vector (Figure 7D, left panel).
GADD45A silencing did not alter the frequency of recom-
bination (Supplementary Figure S11D) but methylation of
GFP was signiﬁcantly stimulated, as shown by MEDIP
analysis (Figure 7D, right panel). Under the same condi-
tions, GADD45A depletion did not modify the methyla-
tion status of b-actin CpG island or of stably methylated
genes, such as H19 (DMR) (Figure 7D).
The transient effects of GADD45A depletion on GFP
expression may be dependent on the transient rise of the
protein (18) and mRNA levels during damage and repair
(Supplementary Figure S10). To address this issue, we
overexpressed the wild-type protein, 2 days after I-SceI
transfection, when endogenous protein levels were
already low. Under these conditions, Ga45a stimulated
GFP ﬂuorescence intensity in H cells for longer periods
(4–7 days after I-SceI), but at day 10 from the DSB, the
effects disappeared (Supplementary Figure S11E and data
not shown). However, 1 month after the DSB or in cells
expressing CMV-EGFP, forced expression or induction of
GADD45A by etoposide did not modify GFP levels (see
the legend of Figure 7).
Taken together, these results indicate that Np95 and
GADD45A favor the generation of L and H cells, respect-
ively, during HDR.
DISCUSSION
Mechanism of DNA repair-induced methylation
The results shown here argue for a link between HDR and
DNA methylation at the site of a repaired DSB. Without
DNA damage and repair, the expression of GFP is stable
and uniform (Supplementary Figure S6, the red peak).
DSB formation within GFP and repair by HDR
Figure 5. Continued
panel, statistical analysis derived from three independent experiments is shown. *P< 0.01, paired t-test comparing GFP intensity, Chi Square (2)
comparing the percentage of L/H cells. The horizontal and vertical arrows in the central inset indicate the shift in ﬂuorescence intensity and in the
distribution of L and H cells, respectively. Treatment with 5azadC (10 mM for 2 days, 48 h after I-SceI transfection) rescued completely the loss of L
cells (intensity and % GFP+ cells) induced by DNMT3a overexpression in siDNMT3a-silenced cells (data not shown). (D) Western blot analysis of
DNMT3a and 3 b in silenced cells. Total cell extracts were prepared 48 h after electroporation and analyzed by immunoblot with the speciﬁc
antibodies indicated. On the right is shown quantitative analysis derived from three immunoblots (mean±SD).
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Figure 6. Np95 (UHRF1) is recruited to repaired GFP and stimulates DNA methylation. (A) ChIP with anti-Np95 antibodies of sorted cells exposed
to a-amanitin during repair. Clones 3 and 4 were transfected with I-SceI and treated with a-amanitin for 24 h as described in Figure 2. The cells were
sorted 5 days after I-SceI transfection and chromatin was collected from formaldehyde-ﬁxed cells and subjected to ChIP analysis with speciﬁc
antibodies to Np95. Primers Bcg and Rec2 were used to amplify recombinant GFP DNA. The data derive from three independent experiments
performed in triplicate (mean±SD; n=9). Differences between treatments were tested for statistical signiﬁcance using Student’s matched pair t-test:
*P< 0.01 as compared with the each control (a-amanitin treated versus untreated cells). Differences between cells (H versus L) were tested for
statistical signiﬁcance using Student’s t-test: **P< 0.01. (B) ChIP analysis of Np95 on H19 DMR and UBE2B genes. qPCR was carried out with
speciﬁc H19 DMR and UBE2B primers on the same samples indicated above. The fraction of immunoprecipitated DNA by control Ig is reported on
each bar graph. (C) DRGFP cells (pool of clones; clone 3 and 4 are not shown here) were transiently transfected with a mixture of siRNAs targeting
speciﬁcally human NP95 or control scrambled siRNA (ctrl) and the mouse I-SceI expression vector (see ‘Materials and Methods’ section). Six days
later, the cells were subjected to FACS analysis and MEDIP. The left panel shows a representative experiment: arrows indicate the shift in silenced
cells of GFP ﬂuorescence intensity. The columns below the ﬂuorescence plot show (i) the number of GFP+ cells (Tot, expressed as percentage of
cells); (ii) the mean ﬂuorescence intensity (Int.); and (iii) Percentage of L and H cells on GFP+ cells. Mean ﬂuorescence intensity at day 7 increased
from 10 to 37 in L cells and from 336 to 460 in H cells (left panel). FACS analysis was performed in triplicate in at least three experiments.
Differences between treatments were tested for statistical signiﬁcance using Student’s matched pair t-test: *P< 0.001 as compared with the each
control (siRNA-treated versus untreated cells). Samples expressing NP95 wild-type and control cells were treated with 1 mM 5azadC for 1 day (48 h
after I-SceI), and the differences in ﬂuorescence intensity was used to quantify methylation-dependent changes of GFP expression. The panel on the
right shows the results of MEDIP immunoprecipitation with anti-5mC antibodies in control and siRNA-treated samples. Np95 depletion by siRNA
did not modify the methylation status of stably methylated genes, such as H19 (DMR) and b-actin CpG island. *P< 0.01 for t-value (matched pair
test) relative to the cells treated with control scramble siRNA (CTRL). Data are expressed as mean±SD, n=9; the average of immunoprecipitated
DNA with a control Ig is reported on the bar graph.
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Figure 7. GADD45 is recruited to the DSB and transiently inhibits de novo methylation induced by HDR. (A) ChIP analysis with anti-GADD45A,
DNMT1 and RNA polymerase II large fragment antibodies in HeLa cells, transfected (36 h) with I-SceI. Twelve hours after transfection, an aliquot
of cells was treated for 24 h with a-amanitin and processed as described in ‘Materials and Methods’ section. Bcg and Rec1 primers were used for
semiquantitative PCR. Two methylated genes, MGM and p16, were used as controls for DNMT1 ChIP. Control IgG represents an average of
nonimmune immunoglobulins used in ChIP. (B) Quantitative analysis by qPCR of at least three ChIP experiments in triplicate (n 9). Differences
between treatments were tested for statistical signiﬁcance using Student’s matched pairs t-test: *P< 0.01 as compared with uncleaved control;
**P< 0.01 compared with I-SceI. The average of immunoprecipitated DNA with a nonimmune Ig is reported on the bar graph. (C) DRGFP
cells (pool of clones) were transiently transfected with siRNA pools targeting speciﬁcally GADD45A or control scrambled siRNA (ctrl) and
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signiﬁcantly alter the methylation pattern of GFP in two
steps. We propose that some actors at this phase are
DNMT1/3 a, Np95 and GADD45A, which transiently
maintain the processed DSB 30 segment hemi-methylated,
until replication generates methylated and
hypomethylated daughter molecules. Figure 8 shows a
simpliﬁed scheme describing the main events during and
after DSB repair: (i) DNMT1 and DNMT3a are recruited
to the DSB with Ga45a and NP95. DNMT3a is recruited
in the ﬁrst 24 h after damage and transiently cooperates
with DNMT1 to methylate repaired DNA. At 48 h, Np95
and Ga45a amplify or limit transiently, respectively,
DNMT1 activity on the hemi-methylated DNA, until rep-
lication duplicates the methylated and unmethylated
DNA strands. This is better shown in the video presented
in the Supplementary Movie, in which time lapse micros-
copy offers a unique snapshot into homologous repair.
The appareance of the GFP signal in I-SceI synchronized
cells can be monitored in the ﬁrst and second cycle after
recombination, relative to the GFP signal, generated by
HDR. In the ﬁrst cycle, H and L cells are formed from the
same cell (square in the Supplementary Movie); in subse-
quent cycles, H and L cells stably propagate in culture the
H or L phenotype (circle in the Supplementary Movie); (ii)
After repair, transcription resumes at day 2–3 after DSB
and progressively modiﬁes local methylation proﬁles until
the local domains of the I-SceI chromatin (loop A in H
cells and loop C in L cells) are stabilize. We believe that
this strand-selection mechanism accounts for the 1:1 L/
H ratio early after repair (Figures. 1 and 4). In fact,
GADD45A exerts its action early during repair (2–4
days), when the L/H ratio is close to 1 and before signiﬁ-
cant remodeling of methylation occurs (Figures 1, 4 and
7). Stalled RNA Pol II by a-amanitin during repair may
facilitate targeting DNMT1/3 a complex to the 30 end ()
transcribed strand, thus promoting hyper-methylation of
the 300 bp repaired DNA segment that lies 30 to the DSB
relative to transcription orientation (Figure 3D and
Supplementary Figure S4). The 30 end (+) strand, free
from transcription proteins, probably is more prone to
invade and ﬁnd the homologous region to direct the an-
nealing, the synthesis and ultimately the repair of the DSB
(Synthesis Directed Strand Annealing, SDSA) (31). This
mechanism may account for the relatively high efﬁcient
HDR in our system.
Remodeling of methylation by transcription after repair
The second step of methylation induced by HDR begins
48 h after formation of the DSB. At this point, repair
is terminated, but chromatin and DNA continue to
undergo epigenetic changes (9,13). H cells progressively
increase and are similar in terms of methylation proﬁle
to a subpopulation of L cells (L2 in Supplementary
Figure S6). Accumulation of these L2/H cells is favored
by continuous transcription of GFP because transient
inhibition of transcription after repair shifts the L/H
ratio and favors accumulation of methylated clones (L2
in Figure 4D). We obtained essentially the same results
shown in Figure 4 by transiently blocking transcription
after repair with a dominant negative cdk9-expression vec-
tor, which inhibits phosphorylation of elongating RNA
polymerase II (G.R., unpublished observations).
However, 27, 30 and 35 days after DNA damage,
inhibition of transcription by exposure to Act-D or
expression of the dominant negative cdk9 did not alter
methylation or expression of GFP (Supplementary
Figure S5). These data indicate that inhibition of
transcription per se does not trigger de novo methylation
(33–35) and suggest that transcription may favor active
demethylation. In fact, depletion of base excision repair
(BER) enzymes (OGG1; APE1) or TDG increased methy-
lation of repaired GFP similarly to Act-D treatment (data
not shown), in agreement with the notion that transcrip-
tion is associated with DNA methylation-demethylation
(32,36) and DNA oxidation cycles (37). We note that the
different effects of a-amanitin and Act-D are related to
the ability of these drugs to increase (a-amanitin,
Supplementary Figure S2B) or deplete (Figure 4D) RNA
polymerase II from chromatin: (i) Stalled pol II during
repair increases targeting and recruitment of DNMT1-
Np95 on the DSB and favors accumulation of L clones;
(ii) depletion or loss of pol II by slow resolution of Act-D/
DNA inhibit transcription and active demethylation.
We suggest that transcription of damaged-repaired
DNA is associated with stochastic replacement of
methylated C by BER or nucleotide excision repair
Figure 7. Continued
the I-SceI expression vector (see ‘Materials and Methods’ section). After 2, 4 and 7 days, the cells were subjected to FACS analysis as described in
Figure 1. FACS analysis was performed in triplicate in at least three experiments. Differences in GFP expression between control and GADD45A-
silenced cells were tested for statistical signiﬁcance using the Chi Square test, T(X) (Population Comparison module of the FlowJo software from
Tree Star). Differences of L and H (percentage and intensity) were tested for statistical signiﬁcance using Student’s t test: *P< 0.01 (see
Supplementary Figure S10). 2 value (4.7), 2 days after I-SceI (control and GADD45A-silenced cells) (P< 0.01); at day 4 and 7, 2 value was
not discriminant as day 2, although differences in ﬂuorescence intensity of L an H cells between the control and GADD45A-silenced cells were
signiﬁcant (P< 0.02). All samples were treated with 1 mM 5azadC for 1 day (48 h after I-SceI) to quantify methylation-dependent changes. (D) Left
panel. Forced expression of GADD45A increases GFP expression. Cells were exposed to siRNA targeting the 30 UTR human GADD45A alone or in
combination with vector expressing GADD45A. GFP ﬂuorescence and Rec mRNA were analyzed 4 days later. The levels of speciﬁc GADD45A
mRNA, the frequency of recombination in GADD45A-depleted cells and the statistical analysis of GFP expression are shown in Supplementary
Figure S8. Differences between populations (control and GADD45A-silenced cells) were tested for statistical signiﬁcance using the Chi Square test
(Population Comparison module of the FlowJo software). Cells expressing CMV-EGFP–treated with etoposide or transfected with Ga45a expressing
vector did not change GFP expression. Right panel. 5mC content of recombinant GFP in cells silenced for GADD45A. Four days after transfection,
the cells were subjected to MEDIP assay. GADD45A depletion by siRNA did not modify the methylation status of stably methylated genes, such as
H19 (DMR) and b-actin CpG island. *P< 0.01 for t value (matched pair test) relative to cells treated with control scramble siRNA (CTRL). All the
samples in independent experiments were treated with 1 mM 5azadC for 1 day (48 h after I-SceI) to quantify methylation-dependent changes. The
average of immunoprecipitated DNA with a control Ig is reported.
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Figure 8. Targeted methylation during and after homologous repair. The cartoon represents a schematic model illustrating the events during and
after repair. The DSB undergoes 50 –> 30 end resection and one of the 30 free single strand end invades the DNA of the GFP cassette II. The half
I-SceI site is removed (ﬂap removal) and new DNA is synthesized. Eventually, the invading strand returns to the original conﬁguration and directs
the synthesis of new DNA at the BcgI site corresponding to the DSB, according to the SDSA model (Synthesis Directed Strand Annealing) (31). We
propose that the asymmetric distribution of methylated CpGs in repaired GFP is caused by selective invasion of the (+) strand. The () strand,
blocked by stalled RNA Pol II (DNMT1 and 3 a), becomes a preferential target of DNMT1-Np95. The hemi-methylated DNA is replicated and
generates H and L cells. After repair, transcription resumes and RNA Pol II-DNMT1 is associated with methylation/demethylation cycles (32) that
in 15 days may remove some methyl groups in a subpopulation of L cells, leading to the conversion of L2 to H 2 cells.
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(NER) followed by repair synthesis (38,39). The events in
this phase are distinct from those leading to the generation
of H and L cells during repair, which are ampliﬁed by
stalled RNA polymerase II and are dependent on Np95
and Ga45a. Under our conditions, GADD45A, transi-
ently induced by DSB, recruited to the DSB, enhanced
accumulation of hypomethylated clones (H) by inhibiting
DNMT1 [Figure 7, Supplementary Figure S11 and (18)]
and disappeared in 3–4 days. This inhibition may repre-
sent a barrier to spreading of repair-induced methylation.
The opposing role of Np95 and GADD45A on DNMT1
activity is not new because DNMT1 stimulation and in-
hibition by Np95 and Ga45a, respectively, are required to
maintain progenitor function in self-renewing somatic
tissue (40).
Evolution and stability of epialleles: qualitative analysis
of methylation
Our data show that the repaired DSB in the GFP gene is
marked locally by de novo methylation. Unlike the GFP
system, in which we induced a site-speciﬁc DSB, DSBs in
genomic DNA are essentially random in terms of sequence
speciﬁcity, although the overall distribution is nonran-
dom, due to chromatin organization (41). Assuming that
methylation marks these DSBs after homologous repair,
the overall distribution of methylated sites in genomic
DNA will appear random in the absence of selective
pressure. We have extended our analysis to homologous
targeting of GFP in ES cells and we ﬁnd that genetically
identical clones express variable GFP levels, due to de
novo methylation or targeted gene (data not shown).
In our system, qualitative analysis of the methylation
proﬁles, i.e. the location of methylated CpG in the
various GFP molecules, 30 end to the DSB, is able to dis-
tinguish repaired GFP molecules from nonrecombinant or
uncleaved molecules (Supplementary Figures S6 and S7).
This discrimination is based on the relatedness of methyla-
tion proﬁles, not on the total methyl CpG content. GFP
DNA molecules, shown in Supplementary Figures S4 and
S6, can be considered epigenetic alleles because their
methylation proﬁles are stable and are inherited in
human and mouse cells over several generations. We have
applied the same type of analysis shown in Supplementary
Figures S6 and S7 to several somatically methylated genes
and we ﬁnd that the epialleles are stable, evolve rapidly
following DNA damage and can be individually tracked
in a complex mixtures of cells. HDR-induced speciﬁc
methylation states may be ultimately responsible for sto-
chastic gene expression in populations of mammalian cells.
In conclusion, we propose that DNA methylation rep-
resents a damage-repair code that modiﬁes the expression
of genes in cell populations and drives adaptation to en-
vironmental challenges. Selection of methylated alleles in
each cell may be relevant for the rapid evolution of cancer
cell phenotypes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [42].
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Oxidative DNA damage induces the ATM-mediated
transcriptional suppression of the Wnt inhibitor
WIF-1 in systemic sclerosis and fibrosis
Silvia Svegliati,1* Giusi Marrone,2* Antonio Pezone,2* Tatiana Spadoni,1 Antonella Grieco,1
Gianluca Moroncini,1,3 Domenico Grieco,2 Maria Vinciguerra,4 Savina Agnese,2 Astrid Jüngel,5
Oliver Distler,5 Anna Maria Musti,6 Armando Gabrielli,1,3† Enrico V. Avvedimento2†
Systemic sclerosis (SSc) is an autoimmune disease characterized by extensive visceral organ and skin
fibrosis. SSc patients have increased production of autoreactive antibodies and Wnt signaling activity. We
found that expression of the gene encoding Wnt inhibitor factor 1 (WIF-1) was decreased in fibroblasts
from SSc patient biopsies. WIF-1 deficiency in SSc patient cells correlated with increased abundance of
the Wnt effector b-catenin and the production of collagen. Knocking down WIF-1 in normal fibroblasts
increased Wnt signaling and collagen production. WIF-1 loss and DNA damage were induced in normal
fibroblasts by either SSc patient immunoglobulins or oxidative DNA-damaging agents, such as ultraviolet
light, hydrogen peroxide, or bleomycin. The DNA damage checkpoint kinase ataxia telangiectasia mutated
(ATM) mediated WIF-1 silencing through the phosphorylation of the transcription factor c-Jun, which in
turn activated the expression of the gene encoding activating transcription factor 3 (ATF3). ATF3 and c-Jun
were recruited together with histone deacetylase 3 (HDAC3) to theWIF-1 promoter and inhibitedWIF-1 ex-
pression. Preventing the accumulation of reactive oxygen species or inhibiting the activation of ATM,
c-Jun, or HDACs restored WIF-1 expression in cultured SSc patient cells. Trichostatin A, an HDAC inhib-
itor, prevented WIF-1 loss, b-catenin induction, and collagen accumulation in an experimental fibrosis
model. Our findings suggest that oxidative DNA damage induced by SSc autoreactive antibodies enables
Wnt activation that contributes to fibrosis.
INTRODUCTION
The Wnt (Wingless) family is a group of highly conserved secreted pro-
teins that regulate cell-to-cell interactions during embryogenesis and is im-
plicated in carcinogenesis, aging, and fibrosis (1). To be effective during
embryogenesis and stem cell differentiation, Wnt signals need to be care-
fully controlled temporally and spatially (2). This is accomplished by a
balance of Wnt-activating proteins or Wnt-inhibiting proteins [for a re-
view, see (3)]. Specifically, inhibitors either bind directly to Wnt, such
as Wnt inhibitory factor 1 (WIF-1), or interact with the Wnt receptor
complex (4).
WIF-1 is a highly conserved gene containing a unique Wnt inhibitory
domain and five epidermal growth factor (EGF)–like repeat domains.
WIF-1 inhibits Wnt signaling during development (5), and it is silenced
during the neoplastic progression of various human cancers (6, 7). In-
creased Wnt signaling is also linked to mesenchymal differentiation and
tissue-specific cellular aging. Unrestrained Wnt signaling decreases the
pool of mesenchymal stem cells and ultimately induces fibrosis (8). Sys-
temic sclerosis (SSc) is a disease characterized by extensive tissue fibrosis,
and Wnt–b-catenin signaling is a key player in fibroblast activation and
tissue fibrosis in SSc (9). We previously showed that fibroblasts derived
from SSc patients undergo senescence prematurely because of extensive
oxidative stress and DNA damage. This phenotype is induced in normal
cells through constitutive activation of platelet-derived growth factor re-
ceptor (PDGFR) signaling by agonistic autoreactive antibodies (10, 11),
but the specific mechanism leading to Wnt activation in SSc cells is not
yet clear. Notably, Wnt activation has different consequences on the fate of
epithelial and mesenchymal cells: DNA damage promotes transformation
or death in epithelial cells (12) but accelerates aging and increases colla-
gen abundance in mesenchymal cells (8, 13). Therefore, we investigated
the mechanism linking the effects of SSc patient–derived immunoglobulins
with the induction of Wnt signaling in either normal or SSc patient fibro-
blasts derived from skin biopsies.
RESULTS
WIF-1 is silenced in SSc patient fibroblasts by promoter
histone deacetylation
Wnt signaling is increased in the skin and fibroblasts of SSc patients com-
pared with the same samples derived from normal subjects (9, 13), sug-
gesting that either the activity of proteins that stimulate the pathway is
increased or that of proteins which inhibit Wnt signaling is decreased.
We found that the abundance of the secreted Wnt inhibitor, WIF-1, was
decreased in skin biopsies from SSc patients compared with normal cul-
tured fibroblasts (Fig. 1, A to C, and fig. S1A). Immunofluorescence de-
tection of WIF-1 in SSc patient fibroblasts further confirmed significantly
decreased WIF-1 abundance, as well as a concomitant increase in that of
b-catenin (Fig. 1D), which is a marker of canonical Wnt signaling. Because
WIF-1 is silenced in breast cancer cells by methylation of its promoter (14),
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and because the abundance of WIF-1 mRNA in a culture of MCF7 breast
cancer cells was similar to that in SSc patient fibroblasts (Fig. 1A), we hy-
pothesized that the same may be true in SSc patient cells. However, in con-
trast to that in MCF7 cells, the WIF-1 gene
was not methylated in SSc patient fibro-
blasts as assessed by bisulphite sequencing
(fig. S1B), and its expression was not restored
by treatment with 5-azacytidine, a demethyl-
ating agent (Fig. 1E). It was, however, re-
stored and further increased by treatment
with the histone deacetylase (HDAC) inhib-
itor trichostatin A (TSA) at both the mRNA
and protein levels (Fig. 1, E and F). In contrast,
the expression ofWIF-1was restored inMCF7
cells only by 5-azacytidine (Fig. 1E), indi-
cating that whereas the loss of WIF-1 may be
caused by DNA methylation in breast cancer
epithelia, its loss is caused by histone de-
acetylation in SSc patient fibroblasts.
WIF-1 silencing enhances
Wnt activity and induces
COL1A1 expression
To investigate the consequences of decreased
WIF-1 expression in SSc cells, we silenced
WIF-1 in normal fibroblasts using targeted
silencing RNAs (siRNAs) and measured
the transcript abundance ofCOL1A1 (encod-
ing collagen type 1 a 1) and CTNNB1 (en-
coding b-catenin). Loss of WIF-1 initially
increased the expression ofCTNNB1 (Fig. 2A).
The abundance of b-catenin at both the tran-
scriptional and translational levels was in-
versely correlated with WIF-1 abundance
(Fig. 2A and fig. S2A), possibly because
of the stabilizing effects of Wnt on b-catenin
(15). COL1A1 mRNA, however, increased
only 96 hours after WIF-1 siRNA transfec-
tion, suggesting an indirect effect of WIF-1
on COL1A1 gene expression (Fig. 2A).
We noticed a significant and unexpected
early inhibition of COL1A1 expression in
the first 48 hours after transfection with
WIF-1 siRNA (Fig. 2A). We speculate that
in the absence of certain growth factors [such
as platelet-derived growth factor (PDGF),
which induces collagen synthesis (10)], a
rapid increase of b-catenin may inhibit rath-
er than stimulate COL1A1 expression.
To this end, we analyzed the effects of
WIF-1 depletion in cells stimulated with
PDGF. Loss of WIF-1 at 72 to 96 hours in-
creased the basal expression of COL1A1 and
prevented PDGF-induced expression of
COL1A1 (Fig. 2, B and C), suggesting that
cells with low abundance of WIF-1 (such as
SSc cells) express increased COL1A1 and are
thus refractory to collagen-inducing signals.
DecreasedWIF-1 correlated with the induction
of b-catenin and T cell factor (TCF)–dependent
transcription in SSc patient cells, as assessed with a luciferase reporter (fig.
S2B), as well as high abundance of b-catenin in idiopathic lung fibrosis cells
(fig. S2C) (16), which is also evident in other fibrotic tissues (17, 18).
Fig. 1. Silencing of WIF-1 in fibroblasts from SSc and in breast cancer cells (MCF7). (A) Reverse
transcription polymerase chain reaction (RT-PCR) for WIF-1 mRNA abundance in serum-starved primary
fibroblasts from six normal subjects (N, means ± SD from fig. S1A) or six SSc patients compared with
MCF7 cells. Data are means ± SD from three independent experiments normalized to 18S RNA abun-
dance. (B) Western blot for WIF-1 in whole-cell lysates from six SSc patients compared with normal
samples. Data are means ± SD from three independent cultures from each patient. AU, arbitrary unit.
(C) Representative immunohistochemistry for WIF-1 and b-catenin in skin biopsies from three SSc and
three normal subjects. Scale bars, 100 mm. (D) Confocal microscopy for WIF-1 and b-catenin in SSc or
normal fibroblasts. Data are means ± SD of at least 50 cells per field from six SSc patients and six normal
subjects. Scale bars, 100 mm. (E and F) Analysis of WIF-1 expression (E) and WIF-1 abundance (F) in
normal or SSc fibroblasts (from six patients each) and MCF7 cells treated with 300 nM TSA or 4 mM
5-azacytidine for 24 hours. Data are means ± SD of three independent experiments. *P < 0.05, **P <
0.01 compared to normal control; ††P < 0.01 compared to SSc.
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Persistent oxidative stress silences WIF-1
To investigate the mechanism that silenced WIF-1, the abundance of
WIF-1 and b-catenin was measured in normal fibroblasts exposed to re-
combinant PDGF or immunoglobulins isolated from normal volunteers
(N-IgG) or SSc patients (SSc-IgG). After 24 hours in PDGF, the abundance
of WIF-1 increased and that of b-catenin
did not change in normal fibroblasts (Fig.
2D). In contrast, exposure to SSc-IgG, but
not N-IgG, decreasedWIF-1 and increased
b-catenin protein abundance. Fibroblasts lack-
ing functional PDGFR showed no changes
in eitherWIF-1 or COL1A1 transcript abun-
dance in response to PDGF or SSc-IgG,
whereas reconstitution of PDGFR restored
the effects of both PDGF and SSc-IgG on
WIF-1 expression and increased the expres-
sion of COL1A1 (fig. S2D). This suggested
that although PDGF and SSc-IgG had op-
posite effects on the abundance of WIF-1,
they appeared to act through the same re-
ceptor. To rule out possible artifacts caused
by contaminants in SSc-IgG fractions and
to demonstrate the biological activity of SSc-
IgG onWIF-1 expression, we tested a recom-
binant IgG (immunoglobulin G) targeting
PDGF that was cloned from lymphocytes
of a scleroderma patient. This IgG reduced
WIF-1 expression (fig. S2E). Because inhi-
bition of HDACbyTSA reactivatedWIF-1 ex-
pression in SSc cells, we tested whether TSA
inhibited SSc-IgG effects. TSA not only re-
verted the effects of SSc-IgG in normal fi-
broblasts but also markedly stimulated the
expression ofWIF-1 and reduced b-catenin
content (Fig. 2D), suggesting that HDAC is
a target of the action of SSc-IgG.
To identify the targets of PDGF and
SSc-IgG in altering WIF-1 expression, we
inhibited reactive oxygen species (ROS),
which mediates the induction of COL1A1
expression by PDGF or SSc-IgG (10). De-
pletion of ROS by diphenyleneiodonium
(DPI), a general inhibitor of ROS-producing
flavoenzymes (fig. S3) (19), prevented the
effects of either PDGF or SSc-IgG on the
expression ofWIF-1 (Fig. 2E). Normal fibro-
blasts exposed to increasing H2O2 concen-
trations differentially affected the expression
of WIF-1, depending on the time and the
concentrations used. Whereas addition of
10 mMH2O2 for 2 hours increasedWIF-1 ex-
pression, exposure to 1 mMH2O2 for 2 hours
significantly decreased it compared to basal
expression (Fig. 2F). Low H2O2 mimicked
the effects of PDGF (inducedWIF-1 expres-
sion), whereas high H2O2 replicated SSc-
IgG action (inhibited WIF-1 expression).
We note that ROS induced by PDGFare tran-
sient and rapid, whereas ROS induced by
SSc-IgG are prolonged (11); this may explain
why only high H2O2 inhibited WIF-1 expression in normal cells. In SSc
cells, ROS persist longer even in the absence of serum or exogenous
SSc-IgG because they sustain an autoamplification loop involving active
extracellular signal–regulated kinase 1 and 2 (ERK1/2) and NADPH (reduced
form of nicotinamide adenine dinucleotide phosphate) oxidase (10).
Fig. 2. WIF-1 silencing amplifies Wnt signaling and induces COL1A1 expression. (A) Normal fibroblasts
were transiently transfected with scrambled or WIF-1–targeted siRNA (siWIF-1). At the indicated times,
the relative expression of endogenousWIF-1, CTNNB1, and COL1A1 was measured by RT-PCR. (B) Rep-
resentative immunofluorescence staining for COL1A1 in control-transfected (siC) or WIF-1–silenced cells
(siWIF-1) for 48 hours, and then stimulated with PDGF (15 ng/ml) for 24 hours. Images were captured at
72 hours after transfection. (C) RT-PCR analysis of COL1A1 andWIF-1 mRNA in fibroblasts treated as in
(B). (D) WIF-1 and b-catenin immunoblot in serum-starved normal fibroblasts pretreated with TSA (300 nM,
1 hour) and then stimulated with PDGF (15 ng/ml, 24 hours) or IgG isolated from three SSc or normal
subjects (200 mg/ml, 24 hours). (E) WIF-1 mRNA abundance (upper panel) and ROS detection (lower
panel) of fibroblasts not treated (basal) or pretreated with DPI (10 mM, 1 hour) and then stimulated with
PDGF (15 ng/ml) or immunoglobulin isolated from three distinct SSc patients (SSc-IgG) (200 mg/ml) for
24 hours. (F) WIF-1 and COL1A1 mRNA abundance in serum-starved normal fibroblasts treated with
H2O2 (10 mM or 1 mM for 2 hours). Data in (A) to (F) are means ± SD of three independent experiments.
*P < 0.05, **P < 0.01 compared to controls; †P < 0.01 compared to SSc-IgG–treated sample (D); ††P < 0.01
compared to PDGF-treated sample (E).
R E S E A R C H A R T I C L E
www.SCIENCESIGNALING.org 2 September 2014 Vol 7 Issue 341 ra84 3
 on February 5, 2015
http://stke.sciencemag.org/
Downloaded from 
Collectively, the data suggest that WIF-1 si-
lencing induced by high or persistent ROS
exposure promotes Wnt signals to respond
to oxidative stress.
DNA damage and checkpoint
kinase ataxia telangiectasia
mutated silence WIF-1
Persistent oxidative stress, caused by H2O2
or ultraviolet (UV) light, for example, can
induce DNA damage and activation of ataxia
telangiectasia mutated (ATM) and the DNA
damage response (DDR) (20). SSc patient–
derived fibroblasts and normal fibroblasts
treated with high concentrations of H2O2 dis-
played conspicuous DNA damage, evident
by the accumulation of phosphorylated ATM
(Fig. 3, A and B) and phosphorylated p53
binding protein 1 (53BP1) (Fig. 3C), hall-
marks of the DDR (20). In SSc fibroblasts,
inhibiting ATM with the competitive inhib-
itor KU55933 (KuDOS 55933) increased
WIF-1 expression and reduced COL1A1 ex-
pression compared to that seen in normal
cells (Fig. 3D). Similarly, DNA damage in-
duced by UV light in normal fibroblasts re-
duced WIF-1 mRNA abundance (Fig. 3E).
Treatment with the ATM inhibitor not only
prevented UV-induced repression of WIF-1
but also increased it basally (Fig. 3E).
The expression of other genes that encode
inhibitors of Wnt signaling, such as axis in-
hibition protein 2, secreted frizzled-related
protein, and glycogen synthase kinase 3
was also inhibited by UV, but was not de-
pendent on ATM (fig. S4), suggesting that
WIF-1 might be a specific target in the
ATM-induced damage response.
To examine whether WIF-1 expression
was inhibited by ROS and ATM through a
single mechanism, we treated normal or
A-T fibroblasts (GM05823) with 250 mM
H2O2,whichwas sufficient to reduceWIF-1 ex-
pression in wild-type fibroblasts (Fig. 3F).
However, in A-T fibroblasts, the same con-
centration of H2O2 did not significantly af-
fectWIF-1 expression (Fig. 3F). Exposure
of normal fibroblasts to higher concentra-
tions (1mM) ofH2O2 silencedWIF-1 expres-
sion and (as confirmation of the functional
effects on Wnt signaling) stimulated b-
catenin abundance, but not in the presence
of the ATM inhibitor (fig. S5), indicating
that ATM was downstream of ROS induc-
tion andmediated the repression ofWIF-1 ex-
pression. This finding agrees with evidence
that ATM can be directly activated by ROS
independently of the DDR-initiating MRE11-
RAD50-NBS1 (MRN) complex (20). How-
ever, to test whether WIF-1 silencing was
Fig. 3. Oxidative DNA damage silences WIF-1. (A) Western blot for
phosphorylated ATM in lysates from SSc fibroblasts or serum-starved
normal fibroblasts pretreated with KU55933 (10 mM, 1 hour) before
H2O2 (10 mM and 1 mM, 2 hours) or cisplatin (5 mM, 24hours). Blots are representative of three independent
experiments. (B) Phosphorylated ATM (Ser1981; red) and DNA (SYTOX Green) in normal or SSc fibroblasts
pretreated with KU55933 (10 mM, 1 hour), and then treated with H2O2 (1 mM, 30 min). Images are repre-
sentative of four independent experiments. Scale bars, 100 mm. (C) Cells treated as in (A) and stained for
53BP1. Images are representative of four independent experiments. Scale bars, 100 mm. (D) WIF-1 and
COL1A1 mRNA expression in normal (N) and SSc fibroblasts in the presence or absence of KU55933
(10 mM, 1 hour). (E) WIF-1 and COL1A1 mRNA abundance in normal fibroblasts pretreated with 10 mM
KU55933 and then exposed to UV (80 J/m2). DMSO, dimethyl sulfoxide. (F) WIF-1 expression in serum-
starved A-T or normal (N) fibroblasts after H2O2 treatment (250 mM, 30 min). Data in (A) to (F) are means ±
SD of three independent experiments. *P < 0.01 compared to basal or control; †P < 0.05 compared to
H2O2-treated sample (A to C) or SSc cells (D); ††P < 0.01 compared to UV-treated cells (E).
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dependent on DDR and not ROS alone, we treated normal or A-T fi-
broblasts cells with bleomycin, which activates the DDR by creating
DNA double-strand breaks (DSBs) and, incidentally, also induces fibro-
sis (21). Bleomycin repressed WIF-1 and
stimulated COL1A1 expression in normal,
but not in A-T, fibroblasts cells (Fig. 4, A
and B, and fig. S6A); instead, WIF-1 tran-
script abundance increased in the presence
of bleomycin in A-T fibroblasts (Fig. 4A),
further supporting a role for ATM in re-
pressingWIF-1 expression. We also knocked
down ATM using targeted siRNA. Deple-
tion of ATM in normal fibroblasts prevented
WIF-1 silencing by bleomycin, whereas ATM
knockdown increased WIF-1 abundance in
SSc patient cells (fig. S6B).
The data thus far have suggested that
ATM is a critical mediator of WIF-1 silenc-
ing in the presence of ROS and DNA dam-
age. However, the question remained whether
oxidative stress, in addition to DNA damage,
was also involved in bleomycin-induced re-
pression of WIF-1. Therefore, we assessed
the abundance of ROS in normal fibroblasts
using the ROS-sensitive fluorescent probe
2′,7′-dichlorfluorescein-diacetate (DCFH-DA)
after treatment with bleomycin in the pres-
ence or absence of the various inhibitors.
ROS were induced by bleomycin, but this
induction was inhibited by the ATM inhib-
itor KU55933 or by the ROS inhibitor DPI
(Fig. 4, C and D), suggesting that ATM pro-
moted ROS abundance in normal fibro-
blasts after bleomycin. Furthermore, DPI
or KU55933 prevented bleomycin-induced
silencing of WIF-1 and the induction of
COL1A1 expression (Fig. 4E). Finally, in
SSc cells, DPI induced the expression of
WIF-1 and reduced that of COL1A1 (fig. S7A),
indicating that the conditions present in SSc
fibroblasts are similar to those in normal
fibroblasts exposed to oxidative stress or
bleomycin. The data shown above suggest
that ATM is both upstream (Fig. 4, C and
D) and downstream (fig. S5) of ROS to in-
hibitWIF-1 expression. However, these data
do not clarify whether ATM induced by ROS
is sufficient to silenceWIF-1 expression in the
absence of classical DNA damage—DSBs—
that selectively activates ATM (22). DSBs are
recognized by ATM that phosphorylates g-
H2AX, the histone variant that specifically
accumulates at DSBs. Cells exposed to a
high concentration of H2O2 accumulate phos-
phorylated g-H2AX, although less efficiently
than bleomycin (fig. S7B), suggesting that
ROS activate ATM both directly by oxidation
(Fig. 3F) (20) and indirectly by inducing DSB.
The data thus far indicate that ROS and
DNA damage silence WIF-1 and activate
collagen. Therefore, we asked whether also other known profibrotic fac-
tors use the same mechanism(s). Specifically, we investigated whether
transforming growth factor–b (TGF-b), which induces ROS and collagen
Fig. 4. ATM is essential for WIF-1 silencing by ROS and bleomycin. (A and B)WIF-1 and COL1A1 expres-
sion in serum-starved A-T or normal (N) fibroblasts during 24 hours of treatment with bleomycin (20 mU/ml).
(C and D) Intracellular ROS after bleomycin (20 mU/ml) in normal fibroblasts pretreated with DPI or
KU55933 (each 10 mM, 1 hour) assessed by fluorescence (C) and confocal microscopy (D). Images
are representative of three experiments. (E) WIF-1 and COL1A1 expression in normal fibroblasts treated
as in (C) and normalized to 18S RNA. (F) WIF-1 and COL1A1 mRNA abundance in normal fibroblasts
pretreated with TSA (300 nM, 48 hours) or NAC, DPI, or KU55933 (each 10 mM, 1 hour) followed by
TGF-b (10 ng/ml, 24 hours). Data in (A) to (F) are means ± SD of three independent experiments. (A, B,
and F) *P < 0.01 against basal, †P < 0.05 against TGF-b–treated samples; (C to E) *P < 0.05 and **P < 0.01
against basal, †P < 0.05 and ††P < 0.01 against bleomycin-treated samples. (G) Immunoblot and confocal
microscopy for phosphorylated ATM in fibroblasts treated with H2O2 (1 mM, 2 hours) or TGF-b (10 ng/ml,
24 hours). Blots and images are representative of three experiments. (H) Immunohistochemistry for WIF-1
and b-catenin in skin from mice subcutaneously injected with either phosphate-buffered saline (PBS)
(Contrl) or bleomycin (Bleo) compared with mice that received intraperitoneal injection of TSA before bleo-
mycin injection (Bleo + TSA). Images are representative of six mice each. Scale bars, 100 mm (D and H).
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(23), had a suppressive effect on WIF-1 expression, and whether it acted
through ATM. Normal fibroblasts were preexposed to one of several in-
hibitors [N-acetyl cysteine (NAC) or DPI to reduce ROS, KU55933 to in-
hibit ATM, or TSA to inhibit HDAC] and treated with TGF-b for 24 hours.
TGF-b reduced WIF-1 expression in a ROS- and HDAC-dependent but
ATM-independent manner, because NAC and DPI, and TSA prevented the
effects of TGF-b on COL1A1 and WIF-1 expression, whereas KU55933
did not (Fig. 4F). TGF-b, under these conditions, did not activate ATM
(Fig. 4G), suggesting that TGF-b–induced ROS can activate HDAC (24–26)
and repress WIF-1, but do not induce DNA damage and ATM. Moreover,
these data show that the effects of ATM and ROS on WIF-1 silencing can
be dissociated and suggest that ROS induced by TGF-b are neither
persistent nor high enough to induce ATM.
Because inhibition of HDAC by TSA or of ATM by KU55933 indi-
vidually increased WIF-1 expression in SSc cells (Figs. 1F and 3D), we
investigated whether TSA and KU55933 inhibit the same signaling
pathway. The effects of TSA and KU55933 on WIF-1 and COL1A1 ex-
pression in SSc cells were not additive (fig. S8), suggesting that their tar-
gets, HDAC and ATM, are in the same pathway.
To test the in vivo relevance ofWIF-1 silencing, and the role of HDAC
therein, we investigated its expression in a standard model of fibrosis in-
duced by bleomycin (27). Briefly, repeated subcutaneous injections of
bleomycin for 24 to 28 days were used to
induce fibrosis in mice, confirmed by a-SMA
(a–smooth muscle actin) abundance and
Masson’s trichrome staining (fig. S9). In
subgroups of bleomycin-treated mice, pre-
treatment with intraperitoneal injections of
TSA for 4 weeks prevented the decreased
WIF-1 and increased b-catenin abundance
observed after bleomycin exposure (Fig. 4H),
suggesting that bleomycin-induced Wnt sig-
naling was mediated by an HDAC-dependent
mechanism in vivo. Whether ATMmediates
this pathway in vivo as well remains to be
investigated.
Transcription factors c-Jun and
activating transcription factor
3 silence WIF-1
To identify the transcription factor (or fac-
tors) responsible for WIF-1 silencing induced
by ROS and DNA damage, we used a
combination of genetic and biochemical
approaches to examine transcription fac-
tors induced by stress or DNA damage.
In primary human fibroblasts, inhibition of
nuclear factor kB (NF-kB), by expressing
the dominant-inhibitor mutant form of the
NF-kB inhibitor IkBa (IkBaM) (fig. S10A)
(28), did not prevent the repression of
WIF-1 in response to H2O2 (fig. S10B),
although it did inhibit that of NF-kB tar-
gets IL6 and CXCL1 in response to tumor
necrosis factor, an activator of NF-kB (fig.
S10C). Similarly, NF-kB inhibition did not
affect WIF-1 expression in SSc fibroblasts
(fig. S10D), indicating that activation of
NF-kB did not mediate transcriptional re-
pression of WIF-1.
We then turned our attention to members of the AP1 family and in-
hibited several of these in SSc cells by expressing one of several dominant-
negative AP1 constructs [TAM67, derived from c-Jun (29), or a-Fos derived
from c-Fos, the human homolog of the retroviral oncogene v-Fos (29)] or
the wild-type Fos-related antigen 1 (FRA1) to titrate possible AP1-linked
repressors (30). Among the two dominant-negative mutants or wild-type
FRA, only TAM increased WIF-1 expression (Fig. 5A), suggesting that
c-Jun inhibits WIF-1 expression. Confirming this hypothesis, partial de-
pletion of c-Jun with siRNA (fig. S11A) increased WIF-1 expression but
did not significantly modify COL1A1 expression in SSc cells (Fig. 5B), sug-
gesting that c-Jun was necessary forWIF-1 repression, but perhaps not for
induction of COL1A1 expression. To find the missing factor regulating
COL1A1 expression, we investigated the abundance of various transcrip-
tion factors that interact with c-Jun. We found that the abundance of activating
transcription factor 3 (ATF3), a cAMP (adenosine 3′,5′-monophosphate)–
responsive element binding (CREB) protein–like stress transcription factor
(31), was greater in SSc cells than in normal fibroblasts (Fig. 5C and fig.
S11B). In SSc cells, partial siRNA-mediated knockdown of ATF3 (fig.
S11C) induced the expression of WIF-1 and reduced that of COL1A1
(Fig. 5D), suggesting that, whereas both c-Jun and ATF3 can silence
WIF-1 in SSc cells, only ATF3 can induce COL1A1 expression. In normal
fibroblasts, ATF3 and c-Jun were each also involved in the bleomycin-induced
Fig. 5. The AP1 family member c-Jun and the stress-induced transcription factor ATF3 silence WIF-1 and
induce COL1A1. (A) WIF-1 mRNA in SSc fibroblasts transfected with the control (C) or an AP1 family
construct-encoding plasmid. (B) RT-PCR (left) or semiquantitative PCR (right) for WIF-1 and COL1A1
mRNA in SSc fibroblasts transfected with c-Jun siRNA (sic-Jun) or control siRNA (siC) for 48 hours. (C)
Confocal microscopy for ATF3 in normal (N) or SSc fibroblasts. Scale bars, 100 mm. One hundred cells per
field were scored. (D) WIF-1 and COL1A1 mRNA abundance in SSc fibroblasts transfected with ATF3
siRNA (siATF3) or control siRNA (siC) for 48 hours, and then treated with TSA (300 nM) for 24 hours, then
lysed. (E and F) RT-PCR (left) or semiquantitative PCR (right) for WIF-1 and COL1A1 mRNA expression in
normal fibroblasts transfected with control siRNA or siRNA against c-Jun (E) or ATF3 (F) for 48 hours and
then treated with bleomycin (20 mU/ml) for 4 hours. Data in (A) to (F) are means ± SD from three inde-
pendent experiments. *P < 0.05 against basal or control, †P < 0.05 compared to bleomycin-treated cells.
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repression of WIF-1; however, only c-Jun appeared to be involved in
bleomycin-induced induction of COL1A1 (Fig. 5, E and F). The different
regulation of COL1A1 in normal and SSc cells may be dependent on the
abundance of other members of the AP1 family in SSc patient cells
(32, 33), but this is speculation and requires further investigation.
To dissect the roles of c-Jun and ATF3 on WIF-1 expression, we
monitored the recruitment of these two factors and a class I HDAC
(HDAC3) to the promoter of WIF-1. In normal and SSc fibroblasts,
ATF3, c-Jun, and HDAC3 each immunoprecipitated with the promoter
of WIF-1, and the abundance of ATF3 and HDAC3 present on the
promoter was increased in SSc patient cells (fig. S12, A to C). In SSc
patient cells, partial knockdown of c-Jun with siRNA (figs. S11A and
S13A) reduced the amount of ATF3 and HDAC3 that were bound to
the WIF-1 promoter (fig. S13, B and C). Partially silencing ATF3 (figs.
S11C and S13D) also reduced the abundance of c-Jun that was bound to
the WIF-1 promoter (fig. S13E), whereas ATF3 knockdown had no sig-
nificant effect on the recruitment of HDAC3 (fig. S13F). Together, the
data suggest that although the amount of c-Jun that bound to WIF-1
promoter in SSc and normal cells was similar (fig. S12B), recruitment of
c-Jun and ATF3 to the WIF-1 promoter in SSc cells was at
least partially reciprocally dependent. We speculate that re-
ciprocal stabilization of a complex between c-Jun and ATF3
(c-Jun/ATF3 complex) and c-Jun–mediated targeting of HDAC3
to the WIF-1 promoter are responsible for WIF-1 silencing.
ATM activates ATF3 and c-Jun
transcription factors
So far, the data indicate that ATM mediates the repression of
WIF-1 after ROS or DNA damage, and that c-Jun and ATF3
have a role in silencingWIF-1 expression in SSc patient cells.
To investigate the link between ATM and the c-Jun/ATF3
complex, we analyzed this mechanism in response to DNA-
damaging agents in normal cells compared with fibroblasts
from ataxia telangiectasia (AT) patients, which are deficient
for wild-type ATM. Unlike that in normal fibroblasts, ATF3
abundance was not induced by H2O2 in A-T fibroblasts
(GM05823) (Fig. 6A). Because A-T fibroblasts additionally
had not shown WIF-1 repression in response to H2O2 (Fig.
3F) or bleomycin (Fig. 4A), and we had inferred that ATF3
mediated the repression of WIF-1 in bleomycin-treated cells
(Fig. 5F), we suggest that the transcriptional repression of
WIF-1 after DNA damage occurs in an ATM-dependent man-
ner in normal fibroblasts.
Therefore, we examined the role of ATM in WIF-1 repres-
sion further by examining possible mediators between ATM
and the c-Jun or ATF3 transcription factors. The phosphoryl-
ation of c-Jun at Ser73 and Thr91 by c-Jun N-terminal kinases
1 and 2 (JNK1/2) (34, 35) was less in AT fibroblasts in response
to H2O2 than in normal fibroblasts (fig. S14), suggesting that
JNK may have a role downstream of ATM in repressing
WIF-1 expression. SSc cells had increased JNK-phosphorylated
c-Jun, comparable to those induced by bleomycin in normal
fibroblasts (Fig. 6B). Another site at the N terminus of c-Jun
(Thr95) is phosphorylated in stressed cells (36), and when mu-
tated to a nonphosphorylatable residue (T95A) reduces JNK-
mediated phosphorylation of c-Jun at Ser91 (35). In SSc cells,
which also had increased ATF3 (Fig. 5C and fig. S11B), ex-
pression of the T95A c-Jun mutant inducedWIF-1 but suppressed
COL1A1 expression (Fig. 6C). In contrast, the phosphomimetic
mutant c-Jun, T95D, did not significantly alter either WIF-1 or
COL1A1 expression (Fig. 6C), possibly because the SSc cells are already
saturated with ATM-phosphorylated c-Jun. We hypothesize that T95A
c-Jun titrates the endogenous phosphorylated protein in heterodimers
(with AP1 or ATF3). Conversely, in normal fibroblasts (in which c-Jun
was not ATM-phosphorylated), the expression of the phosphomimetic
c-Jun mutant T95D suppressed WIF-1 and stimulated COL1A1 expres-
sion, whereas the nonphosphorylatable mutant T95A had no significant
effect (Fig. 6D). In normal fibroblasts, the phosphomimetic mutant
T95D induced ATF3 expression even in the presence of T95A because
ATM-mediated phosphorylation is not active, suggesting that c-Jun phos-
phorylation is essential for ATF3 induction (Fig. 6E).
To investigate whether ATM might be the kinase that phosphorylates
the Thr95 site in c-Jun, HeLa cells (a cancer cell line of epithelial origin
and amenable to transfection) and human fibroblasts were transfected with
hemagglutinin (HA)–tagged wild-type or mutant c-Jun and treated with
bleomycin to activate the pathway thus far investigated. In cell lysates,
immunoprecipitation for the HA tag was performed followed by Western
blotting with an antibody that detects phosphorylated Ser/Thr ATM/ATR
substrates. Only wild-type c-Jun was detected by the antibody in HeLa
Fig. 6. The expression of c-Jun mutated at
Thr95 influences expression of WIF-1,
COL1A1, and ATF3 in normal fibroblasts.
(A) Representative immunoblot for ATF3 in
normal or A-T fibroblasts (GM05823 or AT5B1)
cultured with H2O2 (250 mM, 30 min). (B) Im-
munoblot of phosphorylated c-Jun (Ser73) in
lysates from SSc fibroblasts pretreated or
not with KU55933 (10 mM, 1 hour), and
normal fibroblasts treated with bleomycin
(20 mU/ml, 4 hours). The lower blot is the
upper gel reblotted for c-Jun and mini chromosome maintenance protein MCM7
(loading control). (C and D) RT-PCR analysis for WIF-1 and COL1A1 in SSc (C) and
normal (D) fibroblasts transfected with empty vector [cytomegalovirus (CMV)] or vector
encoding either wild-type or mutant HA-tagged c-Jun (T95A or T95D). Blots for HA be-
low graphs confirm transfection. (E) RT-PCR analysis for ATF3 in normal fibroblasts
transfected with T95D or T95A c-Jun–HA fusions. Blots are representative, and data
in (C) to (E) are means ± SD of three independent experiments. *P < 0.05 compared
to empty vector.
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cells and fibroblasts (fig. S15, A and C). Endogenous c-Jun in HeLa cells
(fig. S15B) or in normal fibroblasts (fig. S15D) exposed to bleomycin was
recognized by this ATM substrate antibody, and the signal was inhibited
by pharmacological inhibition (fig. S15, B and D) or siRNA-mediated
knockdown of ATM (fig. S15E). These data suggest that ATM phosphor-
ylates c-Jun at Thr95. This may facilitate JNK-dependent phosphorylation
of c-Jun (fig. S14) and the induction and recruitment of ATF3 (Fig. 6E)
and HDAC3 (fig. S13C), and ultimately represses WIF-1 expression,
enabling Wnt signaling.
DISCUSSION
We showed that WIF-1 expression is decreased in SSc cells through de-
acetylation induced by oxidative DNA damage, leading to increased Wnt
signaling, associated with fibrosis. The suppression of WIF-1 expression
by oxidative DNA damage and ATM is unique among the Wnt inhibitors,
and the indirect activation of ATF3 by ATM ties this mechanism to an
extensive network of stress-inducible transcription factors (37). A sche-
matic diagram illustrating the various components involved in WIF-1 silenc-
ing and COL1A1 induction in normal and SSc patient fibroblasts is
shown in Fig. 7.
WIF-1 is a ROS marker
Our findings indicate that WIF-1 is a marker of oxidative DNA damage
because ROS induced by short pulses of PDGF or low concentrations of
H2O2 activated its expression, whereas higher ROS exposure silenced it.
b-Catenin abundance asymmetrically followed WIF-1 suppression: low
WIF-1 expression correlated with high total and nuclear b-catenin accu-
mulation, leading to increased Wnt signaling, as seen in colon cells (38)
or in mouse ectoderm (39). ROS can activate ATM directly (20, 40) or
through DNA damage (22), but we also propose that ROS are induced
by the activity of ATM because inhibition of ATM reduced ROS. ATM
seems to be a regulator of cellular ROS, and it may finely tune ROS con-
tent in stressed cells (41, 42). When DNA is damaged, ATM induces ROS
and transiently renders the cell refractory to exogenous signals. This ROS-
adaptive response to stress is conserved in Saccharomyces cerevisiae (43),
and we speculate that high levels of ROS during repair provide selection
for increased fitness of stressed cells.
ATM is critical to the suppression of WIF-1
The transcription of WIF-1 was regulated by ATF3 and c-Jun. ATF3 is a
member of the CREB family and is induced by a variety of stress signals,
including DNA damage (31). c-Jun is a member of the AP1 family of
transcription factors and, by associating with various proteins, regulates
the expression of genes involved in the cellular stress response (44, 45). In
our study, ATF3 was induced in normal cells only when ATM was func-
tional, explaining why ATM-defective cells were unable to respond to
bleomycin. In SSc cells, persistent oxidative stress (10) and DNA damage
maintain a high abundance of ATF3 and phosphorylated c-Jun, which are
recruited to the WIF-1 promoter and silence the gene, resulting in
increased Wnt signaling (9). Our data also suggest that ATM amplifies
the efficacy of JNK-mediated phosphorylation of c-Jun, revealing a pos-
sible explanation for why ATM-defective livers show reduced phosphoryl-
ated c-Jun (46). In our study, under conditions of DNA damage, ROS-adaptive
response induced by ATM stimulates JNK, c-Jun, and, eventually, ATF3
expression (47). Thus, ATF3 and phosphorylated c-Jun enhance Wnt sig-
naling perhaps by two mechanisms: by reducingWIF-1–mediated inhibition
of soluble Wnt, and by cooperating with b-catenin to induce transcription (48).
The mechanism of WIF-1 silencing has implications for
cancer and fibrosis
WIF-1 silencing is a selected phenotype both in stressed mesenchymal
cells and in epithelial neoplastic cells. WIF-1 is one of the most frequent
silenced genes in cancer, and its loss is common in many tumors (14, 49).
Targeted disruption of WIF-1 accelerates osteosarcomagenesis, without
interfering with normal bone development in mice (50). Our data suggest
that persistent oxidative DNA damage initially silences WIF-1 by histone
deacetylation in fibroblasts and possibly other cell types, whereas WIF-1
is silenced predominantly by methylation in epithelial cells (14). We spec-
ulate that in fibroblasts, robust stimulation of histone acetylation can re-
activate the expression of the gene and repress Wnt signaling, whereas in
epithelial cells, WIF-1 silencing may be permanent, irreversible, and pos-
itively selected during neoplastic progression (49, 51).
If WIF-1 silencing occurs in mesenchymal cells, Wnt signaling leads
to senescence and exit from the cycle (52); differentiated myofibroblasts
(6) or myoblasts (8) exit from the cycle, synthesize collagen or a-SMA,
and accumulate ROS and b-catenin, which are the hallmarks of fibrosis
and wound healing (9, 10, 52, 53). PDGF or TGF-b and other soluble
factors (such as the IgG of SSc patients) cooperate efficiently with b-catenin
to activate a transcription program leading to fibrosis and senescence (54).
We propose that WIF-1 silencing is accomplished by two ROS signaling
cascades: (i) low or transient ROS (TGF-b) activate HDAC (22–24), but
not ATM; (ii) high or persistent ROS induce DNA damage and ATM.
From this perspective, fibrosis represents an amplified secretory response
of senescent fibroblasts to DNA damage associated with wound healing
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Fig. 7. Control of WIF-1 expression by stress and DNA damage. Schematic
illustrating the series of events leading to WIF-1 silencing and collagen in-
duction in SSc and normal cells. (A) In SSc, COL1A1 can be induced by
several members of the AP1 family (but not c-Jun), TGF-b signaling
(through SMAD), and by ATF3. DNA damage or ROS activate ATM and
JNK. ATM phosphorylates c-Jun and facilitates the phosphorylation of c-Jun
by JNK. Phosphorylated c-Jun activates ATF3. c-Jun, ATF3, and HDAC3
bind the WIF-1 promoter and repress its transcription. (B) In normal fibro-
blasts, bleomycin induces DNA damage, which activates ATM and ROS,
which in turn activate c-Jun, JNK, and ATF3. As in SSc cells, ATF3, c-Jun,
and HDAC3 are recruited to theWIF-1 promoter and silence the gene. Un-
like in SSc cells, however, c-Jun, in combination with other AP1 family
members (for example, c-Fos), induces b-catenin/TCF–dependent Wnt sig-
naling and COL1A1 expression.
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(55). We speculate that loss of secreted WIF-1 amplifies local Wnt action
and induces a proliferative burst of surrounding epithelial cells and ter-
minal differentiation of fibroblasts. Only cells that have efficiently repaired
the DNA respond to Wnt because damaged cells succumb to apoptosis
through clashing signals of arrest and stimulation of growth. This provides
a robust selection for fitness of epithelial cells surrounding damaged and
senescent fibroblasts. Our findings in a breast cancer epithelial cell line
suggests that methylation of the WIF-1 promoter might reinforce local
Wnt signaling in epithelial cells (56). This finding provides a mechanism
linking ROS, DNA damage, fibrosis, and cancer (57) and may explain the
higher incidence of lung cancer in SSc patients (58).
In conclusion, our findings exploring activated Wnt signaling in fibro-
sis or during neoplastic progression indicate that DNA damage and ge-
nome stability checkpoints link ROS, Wnt, and fibrosis, thus integrating
many apparently heterogeneous phenotypes associated with fibrosis and
cancer.
MATERIALS AND METHODS
Antibody purification
IgGs were purified from the serum of normal and SSc human subjects,
after oral and written informed consent, using gravity flow columns packed
with Protein A/G–agarose following the manufacturer’s instructions (Pierce).
The eluted IgG fractions were subjected to buffer exchange with PBS using
desalting columns (limit of 5 kD) (Pierce). Purity of IgG preparations was
confirmed by immunoblotting with specific cytokine antibodies [PDGF,
TGF-b, and IL-1 to IL-6 (interleukin-1 to -6)]. For the recombinant anti-
body VH PAM-Vk16F4, the VH and VL sequences were cloned from the
cDNA (complementary DNA) of peripheral lymphocytes of an SSc pa-
tient. Sequence analysis identified the VH and VL sequences, which were
inserted into the Xba I–Sac I and Hind III–Eco RI restriction sites, respec-
tively, under the control of the human cytomegalovirus (HCMV) promoter
in the plasmid vector pDR12, which contains an ampicillin resistance gene
for selective amplification (fig. S16). The plasmid was amplified in E. coli
and transfected into Chinese hamster ovary cells, and the IgG was purified
by immunoaffinity. The study was approved by the institutional ethics
committee at the Università Politecnica delle Marche.
Cells and treatments
Human skin fibroblasts were obtained from punch biopsies taken from the
forearms of normal volunteers and from the skin of patients who fulfilled
the preliminary criteria of the American Rheumatism Association for the
diagnosis of SSc, as described previously (42). Mouse embryo fibroblasts
(MEFs) derived from PDGF receptor knockout embryos that do not ex-
press a and b chains of PDGFR subunits (F–/– cells) infected with PDGFR
a subunit (Fa cells) were previously described (11). Fibroblasts, HeLa cells,
and MEFs were grown in Dulbecco’s modified Eagle’s medium (DMEM),
containing glucose (1 g/liter), supplemented with 10% fetal bovine serum
(FBS), penicillin (100 U/ml), and streptomycin (100 g/ml) (Gibco). Human
control (GM00024) and A-T fibroblasts (GM05823 also known as AT5B1)
were obtained from Coriell Institute and maintained in EMEM (Eagle’s
minimum essential medium) supplemented with 15% FBS, penicillin/
streptomycin (100 mU/ml), and 2 mM glutamine (Gibco). For PDGF treat-
ments, subconfluent fibroblasts were treated with IgG (0.2 mg/ml) or recom-
binant PDGF-BB (15 ng/ml) (Sigma) after 4 hours of starvation (0.2% FBS)
for 24 hours. In selected experiments, cells were incubated with 300 nM
TSA (Sigma) for 48 hours, 4 mM 5-aza-2′-deoxycytidine (5-azacytdine;
Sigma) for 24 hours, cisplatinum (5 mM; Sigma) for 24 hours, 10 mM
DPI (Calbiochem) for 1 hour, KU55933 (Calbiochem) for 1 hour, and
bleomycin (20 mU/ml; Sigma) for 4 or 24 hours, as indicated in the rel-
evant legend. For UV experiments, cells were pretreated with 10 mM
KU55933for 1 hour and then irradiated with UV (80 J/m2) and incu-
bated for a further 1 or 2 hours. Cells were transiently transfected with
siRNA against c-JUN (Santa Cruz), ATF-3 (Qiagen), ATM (Qiagen), or
WIF-1 (Santa Cruz), or transfected with the dominant-negative AP1
constructs c-Jun–derived GFP (green fluorescent protein)–TAM67 and
c-Fos–derived GFP–a-Fos plasmids (26), or the T95A or T95D c-Jun
mutant (32) using Lipofectamine 2000 reagent (Life Technologies)
following the manufacturer’s instructions. Cells were processed 48 hours
after transfection, except the WIF-1 siRNA-transfected cells, which were
lysed 72 hours after the transfection.
Western blotting analysis
Total cell lysates were obtained in radioimmunoprecipitation assay (RIPA)
buffer (2.5 mM Na-pyrophosphate, 1 mM b-glycerophosphate, 1 mM
NaVO4, 1 mM NaF; Sigma) supplemented with a cocktail of protease
inhibitors. The samples were stored for 30 min at 4°C and centrifuged
at 10,000 rpm for 10 min at 4°C. Samples were resolved on a 4 to 12%
gradient SDS–polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred onto a nitrocellulose membrane (Life Technologies). After blocking
with 0.5% Tween for 1 hour, immunoblots were incubated with antibodies
against WIF-1 (1:1000; Abcam), b-catenin (1:1000; Abcam), pATM (1:500;
Abcam,), ATM (1: 500; Novus Biologicals), 53BP1 (1:500; Novus Bio-
logicals), b-actin (1:1000; Santa Cruz Biotechnology), phospho-(Ser/Thr)
ATM/ATR substrate antibody (1:1000, Cell Signaling Technology), HA
(1:500; Covance), Ser73 c-Jun (1:1000; Cell Signaling Technology), and
Thr91 c-Jun (1:1000; Cell Signaling Technology) overnight at 4°C. After
incubation with horseradish peroxidase (HRP)–conjugated antibodies
against rabbit or mouse IgG (Santa Cruz Biotechnology) for 1 hour, sig-
nals were detected with ECLWestern Blotting Detection Reagents (Amersham
Bioscience).
ROS detection
Fluorimetric determination of intracellular ROS was carried out using
DCFH-DA (Life Technologies), as previously described (9), using a multi-
well plate reader (Wallac 1420, PerkinElmer). For confocal microscopy
experiments, cells were seeded on coverlids, loaded with 10 mM DCFH-
DA or 10 mM DHE (Life Technologies) for 30 min, washed with PBS,
and then visualized on a confocal microscope Eclipse C1 (Nikon).
Quantitative real-time PCR analysis
Total RNA isolation from normal, scleroderma, and ATM–/– fibroblasts was
isolated with PureLink RNA Mini Kit (Life Technologies) according to
the manufacturer’s instructions. Total RNA (1 g) of each sample was reverse-
transcribed with the iScript cDNA Synthesis Kit (Bio-Rad) according to
the manufacturer’s instructions. Quantitative RT-PCR was performed with
SYBR Green PCR Master Mix (Bio-Rad). Primers sequences for ampli-
fication are represented in table S1. The amplification was carried out through
45 cycles of 95°C for 15 s and 60°C for 1 min in a iCycler iQ Real-Time
PCR Detection System (Bio-Rad). Relative expression was calculated with
the 2–DDCt method.
Methylation analysis using bisulphite genomic sequencing
The promoter region and the entire coding sequence of humanWIF-1 gene
were analyzed for CG content. A CpG island was determined on the basis
of a 200–base pair (bp) length of DNAwith a CG content greater than 50%
and a CpG/GpC ratio greater than 0.5 using CpG plot program (http://www.
ebi.ac.uk/emboss/cpgplot/). Bisulphite genomic sequencing was used to
analyze the methylation patterns of individual DNA molecules. Sodium
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bisulphite conversion of genomic DNA (about 2 mg for each conversion)
was obtained using EpiTect Bisulfite Kit (Qiagen) following the purcha-
ser’s instructions. Amplicons used for methylation analysis were obtained
from about 50 ng of bisulphite threaded genomic DNA. Specific primers
used for these PCRswere as follows:WifBS-Fw1: –409 –390 5′-GAGTGAT-
GTTTTAGGGGTTT-3′, WifBS-Rv1: –16 +5 5′-CCTAAATACCAAAA-
AACCTAC-3′, WifBS-Fw2: 16 +5 5′-GTAGGTTTTTTGGTATTTAGG-3′,
WifBS-Rv2: +242 +263 5′-TCCATAAATACAAACTCTCCTC-3′. Am-
plifications were carried out on 10 ng of bisulphite-treated DNA using
HotStarTaq DNA Polymerase (Qiagen) for 15 min at 95°C, followed by
50 cycles of 30 s at 95°C, 40 s at 53°C, and 1 min at 72°C, then a final
elongation of 10 min at 72°C before holding at 4°C in a final reaction vol-
ume of 50 ml. Confirmation of PCR product quality and freedom from
contamination was established on 2% agarose gels with ethidium bromide
staining. PCR products were cloned into the pGEM-T Easy Vector pro-
vided by Promega pGEM-T Easy Vector System II, following the manu-
facturer’s procedures. Positive-screened colonies contained the unique
sequence of one individual DNA molecule. Plasmid DNA from the se-
lected positive colonies containing vectors with the insert was purified using
the Qiagen Plasmid Mini Kit. Purified plasmids were sequenced in both
directions using T7 and Sp6 primers. Twenty independent clones for each
genomic preparation and fragment of interest were sequenced to deter-
mine the methylation pattern of individual molecules. Sequencing was
performed at the CEINGE Sequencing Core Facility, Naples, Italy.
Bleomycin-induced dermal fibrosis
Skin fibrosis was induced in 6- to 8-week-old C3H/HeJ mice by sub-
cutaneous injection in defined areas of the upper back of bleomycin for
24 to 28 days as described (27).
Histological analysis
Skin sections were fixed in 4% formalin and embedded in paraffin.
Sections (5 mm) were stained with Sirius Red for the analysis of connec-
tive tissue, and dermal thickness was analyzed by measuring the distance
between the epidermal-dermal junction and the dermal–subcutaneous fat
junction at sites of induration in three consecutive skin sections from each
animal. In each series of experiments, the dermal thickness was calculated
as the fold increase compared with the dermal thickness in controls.
Immunohistochemistry
Skin sections were deparaffinized, rehydrated, and stained with WIF-1 and
b-catenin antibodies (1:100; Abcam) overnight at 4°C, washed, and incu-
bated with biotinylated mouse IgG antibody for 1 hour at room tempera-
ture. The peroxidase ABC method was performed for 1 hour using
diaminobenzidine hydrochloride (DAB) as chromogen.
Immunofluorescence
Cells were fixed for 5 min with 4% paraformaldehyde, permeabilized with
0.2% Triton X-100, and incubated with the following primary antibodies
overnight at 4°C: WIF-1 (1:100; Abcam), b-catenin (1:100; Abcam,),
pATM (1:100; Abcam), and type 1 collagen (1:200; Millipore). Cells were
then washed and labeled with Alexa 488– or Alexa 546–conjugated anti-
bodies (Life Technologies) and counterstained with SYTOX Green, a
DNA counterstain for fixed cells (Life Technologies). Controls were incu-
bated with secondary antibodies alone. Cells were analyzed using the con-
focal microscope Eclipse C1 (Nikon).
Chromatin immunoprecipitation
Cells (1 × 106) were fixed by adding formaldehyde directly to culture me-
dium to a final concentration of 1% for 10 min at room temperature and
washed twice using ice-cold PBS containing 1× protease inhibitor cocktail
(Roche Applied Science) and 1 mM PMSF (phenylmethylsulfonyl fluo-
ride). Fixed cells were harvested, and the pellet was resuspended in 200 ml
of SDS lysis buffer [Chromatin Immunoprecipitation (ChIP) Assay Kit,
Upstate]. After 10 min of incubation on ice, the lysates were sonicated
to shear DNA to 300- and 1000-bp fragments. Sonicated samples were
centrifuged and supernatants were diluted 10-fold in the ChIP dilution buf-
fer (ChIPAssay Kit, Upstate). An aliquot (1:50) of sheared chromatin was
further treated with proteinase K, phenol/chloroform-extracted, and precip-
itated to determine DNA concentration and shearing efficiency (input
DNA). The ChIP reaction was set up according to the manufacturer’s in-
structions. Briefly, the sheared chromatin was precleared for 2 hours with
20 ml of Protein A– or Protein G–agarose (Upstate) and 2 mg of nonimmune
IgG (Santa Cruz Biotechnology), and then was divided into two aliquots
and incubated at 4°C for 16 hours with 20 ml of Protein A/G–agarose and
2 mg of the specific antibody ATF3 (Santa Cruz Biotechnology), HDAC3
(Santa Cruz Biotechnology), c-Jun (Santa Cruz Biotechnology), and non-
immune IgG, respectively. Agarose beads were washed with wash buffers
according to the manufacturer’s instructions, and immunoprecipitated DNA
was recovered and subjected to quantitative PCR using the primers indicated
in the legend of the specific figures and in table S1. Primers forWIF-1 ChIP
were (forward) 5′-CGGGTTATCAGGGAGACAGA-3′ and (reverse) 5′-
CTCCCTTTCAGCCAGTAGGA-3′.
Ethical statement
Use of human material was approved by the Institutional Ethical Commit-
tee of Università Politecnica delle Marche, Ancona, Italy, and consent was
obtained from all subjects who participated in this study. All assays were
performed in blind fashion on coded samples.
Statistics
Data were quantified as means ± SD and were analyzed with the non-
parametric Mann-Whitney test. Data were analyzed using Prism 4 (Graph-
Pad Software Inc.). P values less than 0.05 were considered significant.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/7/341/ra84/DC1
Fig. S1.WIF-1 is methylated in MCF7 breast cancer cells, not in normal or SSc fibroblasts.
Fig. S2. WIF-1 silencing induces b-catenin abundance.
Fig. S3. The oxidase inhibitor DPI inhibits ROS accumulation in SSc cells.
Fig. S4. Among Wnt inhibitors, only WIF-1 is silenced by ATM.
Fig. S5. ATM mediates H2O2-induced silencing of WIF-1.
Fig. S6. Loss of ATM restores WIF-1 abundance in SSc fibroblasts and inhibits bleomycin-
induced silencing of WIF-1.
Fig. S7. Inhibition of ROS production in SSc cells increasesWIF-1 expression and inhibits
expression of the gene encoding collagen.
Fig. S8. The effects of HDAC and ATM inhibitors on WIF-1 expression are not additive.
Fig. S9. Bleomycin-induced skin fibrosis is inhibited by an HDAC inhibitor, TSA.
Fig. S10. NF-kB does not mediate WIF-1 silencing induced by ROS.
Fig. S11. Efficiency of c-Jun and ATF3 knockdown.
Fig. S12. ATF3, c-Jun, and HDAC3 are recruited to the WIF-1 promoter in SSc cells.
Fig. S13. The recruitment of c-Jun to the WIF-1 promoter in SSc cells is partially
dependent on ATF3.
Fig. S14. Phosphorylation of c-Jun is induced by H2O2 in wild-type, but not in A-T, cells.
Fig. S15. c-Jun is a substrate of ATM in HeLa cells and human fibroblasts exposed to
bleomycin.
Fig. S16. pDR12 plasmid construct.
Table S1. List of primers.
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